Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

C3_BASAL_CELL_CARCINOMA_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91 Hospital discharge: ICD-9 — 173[0-9]A Cause of death: ICD-10 — C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91 Cause of death: ICD-9 — 173[0-9]A Cancer registry: Topography ICD-O-3 — C44 Cancer registry: Morphology ICD-O-3 — 809[0-8] Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	26953
4. Check minimum number of events None	26953
5. Include endpoints None	26953
6. Filter based on genotype QC (FinnGen only)	26953

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BASAL_CELL_CARCINOMA_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C44[0-9]1
HD_ICD_9	173[0-9]A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C44[0-9]1
COD_ICD_9	173[0-9]A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C44
CANC_TOPO_EXCL
CANC_MORPH	809[0-8]
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Basal cell carcinoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Basal cell carcinoma

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	26953	13066	13887
Unadjusted period prevalence (%)	5.31	4.45	6.12
Median age at first event (years)	68.48	67.10	69.79

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11857: Matched controls
100048

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

HAB40

NOMESCO Finland

Wedge excision of mammary gland

24.7

323.0

503

179

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1178.1

323.0

5254

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

9.7

323.0

1785

1788

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1538.5

323.0

505

SPAT1153

SPAT

Removal of sutures

2.4

323.0

4802

21928

ZXC50

NOMESCO Finland

Cryotherapy

11.1

323.0

772

621

S77

ICPC

Malignant neoplasm of skin

133.1

323.0

426

PJA12

NOMESCO Finland

Sentinel node biopsy

395.1

323.0

832

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

543

L02BG04

ATC

letrozole; oral

43.1

323.0

481

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

323.0

2195

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

1655.9

323.0

537

TQW99

NOMESCO Finland

Other minor procedure on skin

8.4

323.0

1211

1338

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

5359.9

323.0

612

R23.8

ICD-10 Finland

Other and unspecified skin changes

5.5

323.0

3783

7815

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.5

323.0

2604

3622

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

538

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

12.9

323.0

627

430

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

6.2

323.0

1461

2225

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

528.1

323.0

365

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

323.0

602

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

277.6

323.0

478

A04AA02

ATC

granisetron; systemic, transdermal

183.9

323.0

441

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

346

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

3108.9

323.0

366

L57.0

ICD-10 Finland

Actinic keratosis

8.9

323.0

2698

3200

S18

ICPC

Laceration/cut

2.5

323.0

6030

29151

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

5785

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

13.9

323.0

802

521

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

653.6

323.0

864

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

33.4

323.0

4287

1667

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

323.0

1078

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

100.7

323.0

448

ZZR00

NOMESCO Finland

Flap of skin

46.2

323.0

912

180

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

13.1

323.0

630

427

H02AB02

ATC

dexamethasone; systemic

17.4

323.0

797

412

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

323.0

426

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

488.8

323.0

1949

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

364.5

323.0

419

115

Kela drug reimbursment

Breast cancer

+∞

323.0

719

C61

ICD-10 Finland

Malignant neoplasm of prostate

364.7

323.0

579

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

318.5

325

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

483.2

316.4

335

DHB00

NOMESCO Finland

Excision of lesion of external nose

50.6

312.0

400

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

507.3

277.9

294

HAC20

NOMESCO Finland

Total mastectomy

146.7

270.5

305

L03AA13

ATC

pegfilgrastim; parenteral

594.7

262.1

276

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

247.5

261.5

285

L82

ICD-10 Finland

Seborrhoeic keratosis

2.5

258.5

2519

9807

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1147.7

255.0

265

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

252.6

258

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

19.3

252.4

410

185

WF003

NOMESCO Finland

Adjuvant radiotherapy

162.4

252.1

282

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

198.6

250.1

276

L02BA01

ATC

tamoxifen; oral

104.5

249.5

290

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

10.3

247.4

526

450

WF002

NOMESCO Finland

Radical radiotherapy

43.9

242.6

319

D06BB10

ATC

imiquimod; topical

5.2

236.1

811

1401

116

Kela drug reimbursment

Prostate cancer

+∞

235.9

241

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

148.2

213.9

241

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

15.1

213.8

380

219

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

6.6

212.3

595

795

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

949.0

211.9

221

ZXC15

NOMESCO Finland

Use of photodynamic technique

19.4

211.0

342

153

JN4BD

NOMESCO Finland

Extensive body CT

4.0

209.0

940

2124

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

909.6

203.1

212

L01BC06

ATC

capecitabine; oral

+∞

201.5

206

C50.99

ICD-10 Finland

Breast, unspecified

874.6

195.3

204

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

153.2

190.5

214

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

187.8

192

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

839.7

187.5

196

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

74.8

187.1

226

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

182.8

187

HA1AA

NOMESCO Finland

X-ray mammography

4.6

182.0

694

1334

A03FA01

ATC

metoclopramide; systemic, rectal

2.4

181.7

1738

6563

A04AA55

ATC

palonosetron, combinations; systemic

+∞

179.9

184

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

179.9

184

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

179.9

184

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.4

179.1

591

969

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

796.1

177.7

186

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

169.1

173

ZX090

NOMESCO Finland

Other technic of radiotherapy

125.3

166.4

190

WF049

NOMESCO Finland

Radiotherapy of metastasis

501.0

166.2

176

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

165.2

169

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

1522.8

165.0

171

L03AA02

ATC

filgrastim; parenteral

53.8

163.4

207

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

160.3

164

S82

ICPC

Naevus/mole

2.3

159.6

1670

6569

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

6.2

156.3

458

647

S21

ICPC

Skin texture symptom/complaint

2.3

154.0

1665

6643

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

150.5

154

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

23.7

148.8

226

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

3.9

147.6

669

1510

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

147.6

151

XX3DW

NOMESCO Finland

Time consuming IT work

3.4

146.7

800

2102

JN4AD

NOMESCO Finland

Body CT examination

4.1

145.1

623

1339

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

195.4

144.9

160

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

3.5

144.0

750

1901

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1289.1

142.5

148

C50

ICD-10 Finland

Malignant neoplasm of breast

222.7

142.4

156

S29

ICPC

Skin symptom/complaint other

2.0

141.6

2124

9755

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

62.5

141.5

175

XQ848

NOMESCO Finland

Dermatological photography

5.2

137.2

459

762

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

134.8

138

A04AA01

ATC

ondansetron; systemic, rectal

4.7

133.6

495

919

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

29.2

133.2

191

ZZA00

NOMESCO Finland

Split skin graft

5.2

132.6

446

745

A04AD12

ATC

aprepitant; systemic

245.5

131.2

143

ZZA50

NOMESCO Finland

Full thickness skin graft

38.4

130.0

175

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

4.7

129.3

474

870

ZXC20

NOMESCO Finland

Use of chemical agents

7.6

128.4

322

364

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

127.0

130

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

126.8

3094

16769

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

13.0

125.3

236

156

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

6.0

123.3

367

528

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

123.1

126

ZX080

NOMESCO Finland

Image guided radiotherapy

186.2

118.3

131

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

118.2

121

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

356.4

117.7

126

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

527.3

117.3

124

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

103.9

115.4

134

XQ845

NOMESCO Finland

Dermatoscopy

8.9

115.2

262

252

NK6AN

NOMESCO Finland

Total body bone isotope imaging

21.6

114.9

179

CBB30

NOMESCO Finland

Excision of lesion of eyelid

4.0

113.6

502

1104

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

4.2

111.8

465

967

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.8

111.5

403

728

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

255.1

109.5

119

X76

ICPC

Malignant neoplasm breast female

327.6

108.0

116

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

66.3

107.8

132

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

106.4

109

Y77

ICPC

Malignant neoplasm prostate

128.9

106.4

121

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

105.5

108

L03AA14

ATC

lipegfilgrastim; parenteral

901.4

101.5

106

CBA10

NOMESCO Finland

Biopsy of eyelid

10.0

101.0

216

186

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

454.0

100.8

107

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

11.5

100.6

200

149

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

100.6

103

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

32.3

100.3

140

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

98.6

101

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

875.6

98.6

103

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

875.6

98.6

103

DAB00

NOMESCO Finland

Excision of lesion of auricle

14.0

98.6

179

109

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

867.1

97.6

102

ZQZ00

NOMESCO Finland

Treatment of several skin areas

28.4

97.2

140

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.5

97.2

372

713

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

118.1

96.9

111

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

96.7

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

12.5

94.7

181

124

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

94.7

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

18.5

94.2

154

Z51.5

ICD-10 Finland

Palliative care

5.9

93.8

281

408

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

93.7

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

93.7

L02BB03

ATC

bicalutamide; oral

824.1

92.8

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

146.1

91.6

103

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

63.6

91.0

112

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

90.8

D06BX02

ATC

ingenol mebutate; topical

6.6

89.9

249

326

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

798.4

89.8

C44

ICD-10 Finland

Other malignant neoplasms of skin

75.9

89.1

107

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

18.8

87.9

143

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

86.9

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

85.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

104.2

84.6

L02BG03

ATC

anastrozole; oral

44.6

84.4

110

DAB10

NOMESCO Finland

Partial excision of auricle

133.2

83.0

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.7

82.8

608

1939

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

372.3

82.4

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

729.8

82.1

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

82.0

S26

ICPC

Fear of cancer of skin

7.4

81.9

209

243

WF004

NOMESCO Finland

Palliative radiotherapy

191.2

81.6

ZXC96

NOMESCO Finland

Robot assisted procedure

8.1

80.7

193

203

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

363.7

80.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

80.0

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

80.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

79.1

3341

20427

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

79.1

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

687.0

77.2

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

78.2

77.0

D22

ICD-10 Finland

Melanocytic naevi

2.9

76.9

519

1570

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

180.5

76.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

76.1

2572

14882

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

669.9

75.3

L02AE02

ATC

leuprorelin; implant, parenteral

8.9

74.4

169

163

WZC30

NOMESCO Finland

Teaching

1.9

73.0

1140

5207

S08

ICPC

Skin colour change

2.5

71.5

603

2080

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

635.7

71.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

70.3

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

9.1

69.7

156

147

L02BG06

ATC

exemestane; oral

618.6

69.4

TQW20

NOMESCO Finland

Tatoe

40.7

68.8

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

610.0

68.4

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

68.3

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

161.3

68.2

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

110.4

67.8

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

67.3

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

16.0

67.1

115

127

Kela drug reimbursment

Transplant complication

4.5

67.1

255

486

128

Kela drug reimbursment

Cancers of female genital organs

303.6

66.9

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

3.8

66.8

301

673

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

2.8

66.6

465

1438

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

592.9

66.5

B01AB05

ATC

enoxaparin; parenteral

1.5

66.5

2895

17684

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

16.3

66.3

113

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

299.3

66.0

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

93.4

65.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

65.8

1915

10612

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

20.9

64.6

101

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

558.7

62.6

JN4CD

NOMESCO Finland

Very extensive body CT

4.0

62.6

267

569

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.1

62.2

148

155

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

101.8

62.1

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

60.5

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

16.7

60.5

102

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

17.2

59.3

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

524.6

58.7

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

516.0

57.8

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

57.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

264.9

57.3

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

56.6

C90.0

ICD-10 Finland

Multiple myeloma

256.1

55.4

Z51.0

ICD-10 Finland

Radiotherapy session

490.4

54.9

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.8

54.8

385

1192

ZXA00

NOMESCO Finland

Right side

1.5

54.7

2763

17284

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

11.0

54.3

109

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

54.3

621

2490

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

4.2

54.2

220

448

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

54.1

504

1831

WX402

NOMESCO Finland

General anaesthesia

1.6

53.9

1430

7691

A79

ICPC

Malignancy NOS

52.4

53.9

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

481.9

53.9

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

105.1

53.7

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

53.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

53.2

4420

30234

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

103.4

52.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.6

52.8

195

362

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

52.7

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

51.7

788

3549

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

51.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

51.2

726

3180

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.2

51.2

168

274

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.0

51.2

320

921

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

50.7

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

50.7

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

234.0

50.6

R4110

NOMESCO Finland

Physiotherapy

1.4

50.5

2552

15922

KCD02

NOMESCO Finland

Transurethral resection of bladder

12.9

50.4

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

120.8

50.1

WF001

NOMESCO Finland

Preoperative radiotherapy

447.7

50.0

XKD00

NOMESCO Finland

Uroflowmetry

1.7

49.8

1229

6469

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

49.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

49.4

4233

28998

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

48.8

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

+∞

48.8

WX110

NOMESCO Finland

Local anesthesy

1.3

48.5

7049

52330

ZX120

NOMESCO Finland

Intravenous

1.9

48.4

720

3212

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

36.7

48.3

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

220.7

47.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

422.1

47.1

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

46.8

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

3.1

46.8

276

764

ZZS00

NOMESCO Finland

Rotation flap

67.9

46.2

J01DB01

ATC

cefalexin; oral

1.4

46.2

8841

68204

ZXA05

NOMESCO Finland

Left side

1.4

46.2

2498

15744

QAE99

SPAT

6.6

44.5

121

156

B01AB10

ATC

tinzaparin; parenteral

2.2

44.0

491

1945

Z94.0

ICD-10 Finland

Kidney transplant status

4.2

43.9

179

367

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

43.9

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

43.9

WX002

NOMESCO Finland

Sedation and analgesia

1.5

43.3

1995

12166

S79

ICPC

Neoplasm skin benign/unspecified

3.4

43.2

226

574

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.5

43.1

216

530

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

42.9

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

42.9

KC1GB

NOMESCO Finland

Cystography with X-ray

18.0

42.9

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

379.5

42.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

41.9

WW500

NOMESCO Finland

Blood transfusion

3.3

41.9

225

583

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

61.8

41.6

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

61.8

41.6

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

101.6

41.6

L04AA06

ATC

mycophenolic acid; systemic

3.1

41.4

238

648

1CD02

NOMESCO Finland

+∞

41.0

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

41.0

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

60.6

40.7

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

30.2

40.7

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

40.0

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

40.0

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

40.0

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

59.4

39.8

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

13.6

39.7

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

353.9

39.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

47.0

39.1

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

39.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

38.9

544

2369

S15

ICPC

Foreign body in skin

1.9

38.8

651

3028

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

66.4

38.8

E0000UV

ATC

1.3

38.5

3781

26165

L04AD01

ATC

ciclosporin; systemic

2.9

38.5

243

706

UJF32

NOMESCO Finland

Coloscopy

1.4

38.4

2525

16399

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

38.0

997

5319

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

38.0

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

76.2

37.8

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

13.7

37.7

J01MA02

ATC

ciprofloxacin; systemic

1.3

37.5

3766

26115

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

37.1

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

7.9

36.6

ZX112

NOMESCO Finland

Subcutaneous

4.6

36.6

134

248

ZZR10

NOMESCO Finland

Flap of skin and muscle

13.6

36.5

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

328.3

36.5

TQW40

SPAT

2.2

36.4

375

1434

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

36.1

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

36.1

L04AA01

ATC

[U] ciclosporin; systemic

3.1

36.0

210

576

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

36.0

1279

7349

TQW80

NOMESCO Finland

Local dermatologic skincare

2.5

36.0

297

1015

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

35.9

728

3603

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

319.8

35.5

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.3

35.2

190

495

N02AA05

ATC

oxycodone; systemic

1.6

35.2

903

4785

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

35.1

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

35.1

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

311.3

34.6

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

33.1

34.4

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

34.1

L02BX02

ATC

degarelix; parenteral

+∞

34.1

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

34.1

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

34.1

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

34.1

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

34.1

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

69.5

34.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

34.0

1066

5945

UKC02

NOMESCO Finland

Cystoscopy

1.5

33.8

1255

7279

XX1XN

NOMESCO Finland

Other isotope examination

302.7

33.6

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

4.1

33.6

138

287

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

33.5

289

1009

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.8

33.4

118

211

JN6AD

NOMESCO Finland

CT of torso and neck

7.5

33.2

L01AX03

ATC

temozolomide; systemic

+∞

33.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

33.0

933

5069

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

2.8

32.9

218

653

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

44.4

32.6

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.1

32.5

130

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

32.3

636

3116

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

104.4

32.2

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

32.2

C44.00

ICD-10 Finland

Malignant tumor of the lip skin without histology

+∞

32.2

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

32.2

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

32.2

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.7

31.6

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

31.5

1170

6784

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

21.4

31.3

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

31.3

3221

22280

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.0

31.3

133

286

HAE99

NOMESCO Finland

Other reconstruction of breast

14.8

31.0

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

30.8

135

298

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

277.1

30.7

N02BE01

ATC

paracetamol; systemic, rectal

1.3

30.5

9319

73752

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

143.8

30.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

62.7

30.4

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

13.3

30.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

30.2

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

30.2

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.2

30.1

117

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

24.8

30.0

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.0

30.0

182

515

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

52.1

29.6

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.0

29.3

179

510

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

29.3

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

29.3

KAC10

NOMESCO Finland

Total nephrectomy with capsule

18.1

29.1

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

8.1

29.1

R50.9

ICD-10 Finland

Fever, unspecified

1.5

29.0

992

5637

D70.82

ICD-10 Finland

Drug-induced neutropenia

6.2

29.0

110

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.5

28.9

137

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

264.3

28.8

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

264.3

28.8

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

6.5

28.7

102

J05AB11

ATC

valaciclovir; oral

1.5

28.3

1196

7116

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

28.3

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

15.6

28.2

D23

ICD-10 Finland

Other benign neoplasms of skin

2.7

28.2

201

634

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.3

28.1

105

D06BX01

ATC

metronidazole; topical

1.5

28.1

1071

6234

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

27.9

2184

14477

M05BX04

ATC

denosumab; parenteral

2.1

27.8

348

1449

R23

ICD-10 Finland

Other skin changes

3.6

27.7

133

318

L01CA04

ATC

vinorelbine; systemic

+∞

27.3

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

27.3

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

27.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

27.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

27.2

446

2058

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

47.9

26.9

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

246.6

26.9

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

246.6

26.9

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

246.6

26.9

L91.0

ICD-10 Finland

Hypertrophic scar

3.6

26.7

127

302

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

126.8

26.7

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

10.4

26.6

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.2

26.5

296

1175

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

5.7

26.5

117

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

26.3

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

+∞

26.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

26.3

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

3.9

26.2

114

251

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

26.2

224

780

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.8

26.1

175

531

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

237.8

25.9

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.7

25.7

115

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

65.6

25.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

25.6

1718

11105

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

25.4

709

3836

8094/3-C44.9

ICD-O-3

Basosquamous carcinoma of skin, NOS

+∞

25.4

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

25.4

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

25.4

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

25.4

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

20.6

25.3

D03.5

ICD-10 Finland

Melanoma in situ of trunk

9.8

25.3

9734

FHL

Excision and local plastic or associated free skin grafting

4.8

25.2

157

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

25.1

1642

10568

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

45.1

25.0

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

10.3

25.0

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

229.1

24.9

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

229.1

24.9

A12AA04

ATC

calcium carbonate; oral

2.9

24.8

160

475

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

17.8

24.8

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

118.4

24.8

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

14.6

24.7

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

11.3

24.7

J05AB01

ATC

aciclovir; systemic

1.3

24.5

1916

12669

F16

ICPC

Eyelid symptom/complaint

1.8

24.5

448

2145

C44.70

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including the hip without histology

+∞

24.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

24.4

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

24.4

EAA20

NOMESCO Finland

Partial excision of upper lip

+∞

24.4

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

24.1

410

1916

ZX095

NOMESCO Finland

Combined chemoradiotherapy

220.3

24.0

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

220.3

24.0

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.3

23.9

233

870

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

11.1

23.9

A02BC02

ATC

pantoprazole; systemic

1.2

23.9

6689

51458

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

61.4

23.9

WW300

NOMESCO Finland

Transfer of autologic stem cells

61.4

23.9

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

114.1

23.8

153

Kela drug reimbursment

Lenalidomid

78.9

23.8

SPAT1325

SPAT

Vaccination

1.3

23.7

3167

22480

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

23.6

876

5065

C43

ICD-10 Finland

Malignant melanoma of skin

37.4

23.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

23.4

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

23.4

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

23.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

23.4

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

23.4

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

23.4

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

23.4

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

23.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

23.4

G04BE03

ATC

sildenafil; oral

4.6

23.4

155

SPAT1324

SPAT

Screening procedure

0.7

23.2

864

10102

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.7

23.2

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

49.0

23.1

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

109.9

22.9

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

32.7

22.8

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.4

22.5

112

277

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

22.4

20199

ICD-8 Finland

Hodgkin's disease

+∞

22.4

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

22.3

5125

38523

J01MA12

ATC

levofloxacin; systemic

1.3

22.3

1518

9817

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

5.4

22.3

108

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

11.4

22.3

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

202.8

22.1

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

18.5

22.0

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

22.0

371

1729

L04AX04

ATC

lenalidomide; oral

105.7

21.9

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

3.8

21.9

210

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

21.8

1528

9923

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.0

21.6

126

351

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

21.6

1107

6821

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

21.6

156

498

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

21.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

21.5

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

21.5

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

21.5

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

21.5

180

Kela drug reimbursment

Interferon alfa

+∞

21.5

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

21.4

1911

12852

B07.9

ICD-10 Finland

Verruca simplex

2.0

21.4

295

1279

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

8.8

21.4

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

2.9

21.4

135

397

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

21.4

196

712

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.9

21.3

325

1466

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

54.9

21.1

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

54.9

21.1

QAE15

NOMESCO Finland

Excision of other superficial lesion of skin from head and neck

10.1

21.0

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

10.1

21.0

WF090

NOMESCO Finland

Profylactic radiotherapy

101.4

21.0

N63

ICD-10 Finland

Unspecified lump in breast

1.8

21.0

399

1938

D23.4

ICD-10 Finland

Benign neoplasm: Skin of scalp and neck

3.2

20.9

112

294

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

14.5

20.8

SPAT1211

SPAT

Application of soft bandage

1.5

20.7

766

4424

G04CA02

ATC

tamsulosin; oral

1.3

20.6

1610

10621

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.2

20.5

S04

ICPC

Lump/swelling localized

1.5

20.5

793

4621

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.6

20.5

150

483

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

20.5

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

20.5

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

20.5

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

20.5

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

13.0

20.4

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.7

20.4

131

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

14.8

20.4

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.8

20.3

124

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

20.3

2307

16006

XX1AD

NOMESCO Finland

Other CT-examination

29.6

20.2

KEB00

NOMESCO Finland

Biopsy of prostate

5.3

20.2

100

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

24.5

19.9

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

32.6

19.9

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

19.6

119

342

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

19.5

137

431

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

19.5

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

19.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

19.5

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

19.5

L02BB04

ATC

enzalutamide; oral

+∞

19.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

19.5

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

19.4

697

3998

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

7.1

19.2

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

177.4

19.2

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

19.2

2130

14723

TK800

NOMESCO Finland

Hemodialysis

2.2

19.2

197

757

C44.5

ICD-10 Finland

Malignant neoplasm: Skin of trunk

64.9

19.2

A11CC03

ATC

alfacalcidol; systemic

2.2

19.1

196

751

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

19.1

166

587

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.2

18.9

102

270

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

18.9

222

905

Z31.5

ICD-10 Finland

Genetic counselling

1.9

18.7

273

1211

R31

ICD-10 Finland

Unspecified haematuria

1.5

18.6

669

3840

HA1HA

NOMESCO Finland

Tomosynthesis mammography

8.7

18.6

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

18.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

18.5

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

18.5

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

18.5

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

18.5

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

18.5

HAC25

NOMESCO Finland

Radical mastectomy

+∞

18.5

C44.1

ICD-10 Finland

Malignant neoplasm: Skin of eyelid, including canthus

+∞

18.5

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

18.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

18.5

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

18.5

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

18.5

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

18.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

18.5

2338

16408

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

3.2

18.4

100

266

B03XA01

ATC

erythropoietin; parenteral

3.9

18.4

166

PJW99

NOMESCO Finland

Other operation on lymphatic system

48.6

18.4

JAL30

NOMESCO Finland

Omentectomy

5.4

18.2

L02AE04

ATC

triptorelin; parenteral

19.7

18.1

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.7

18.1

416

2140

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

18.0

188

727

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

17.9

2229

15605

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

33.8

17.9

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

17.8

366

1819

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

9.2

17.8

L04AX01

ATC

azathioprine; systemic

1.7

17.7

396

2020

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

17.6

530

2920

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.8

17.6

169

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

17.6

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

17.6

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

17.6

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

17.6

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

17.6

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

17.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.6

17.5

240

3446

EAA10

NOMESCO Finland

Excision of lesion of lip

2.8

17.5

117

359

JG1BG

NOMESCO Finland

MRI of rectum

11.6

17.4

JFB30

NOMESCO Finland

Right hemicolectomy

4.2

17.4

134

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

6.0

17.4

D75

ICPC

Malignant neoplasm colon/rectum

19.0

17.3

9706

FHL

Ablation mammae, includes axillary exploration

160.5

17.3

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

17.1

108

317

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

17.1

366

1844

KAD00

NOMESCO Finland

Partial nephrectomy

9.9

17.1

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

17.0

250

1114

7151

FHL

Kidney transplantation

11.8

17.0

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

16.9

633

3667

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.7

16.8

116

362

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

25.4

16.8

JFF23

NOMESCO Finland

Transversostomy

5.3

16.7

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

16.6

307

1479

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

5.9

16.6

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

16.6

8094/3-C44.3

ICD-O-3

Basosquamous carcinoma of skin of other and unspecified parts of face

+∞

16.6

C44.49

ICD-10 Finland

Malignant tumor of the skin of the scalp and of the neck other or unspecified histology

+∞

16.6

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

16.6

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

16.6

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

16.6

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

16.6

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

16.6

137

Kela drug reimbursment

Uraemia requiring dialysis

3.0

16.4

283

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

152.1

16.3

189

Kela drug reimbursment

Imatinib

152.1

16.3

QBE99

SPAT

3.6

16.3

177

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

16.2

476

2606

J01EA01

ATC

trimethoprim; systemic

1.2

16.2

2150

15140

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

16.1

165

633

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.5

16.1

126

424

-54

ICPC

Repair/fix-suture/cast/prosth device

2.0

16.0

213

917

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

15.8

209

895

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.5

15.8

177

TQB05

NOMESCO Finland

Puncture of skin of trunk

5.2

15.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

15.7

129

445

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

15.6

390

Kela drug reimbursment

Ibrutinib

+∞

15.6

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

15.6

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

15.6

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

15.6

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

15.6

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

+∞

15.6

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

15.6

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

15.6

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

15.6

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

15.6

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

15.6

N18.0

ICD-10 Finland

End-stage renal disease

2.7

15.6

108

339

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.3

15.5

140

507

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

15.5

596

3471

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

9.7

15.5

C56

ICD-10 Finland

Malignant neoplasm of ovary

53.5

15.5

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

143.6

15.4

K62.7

ICD-10 Finland

Radiation proctitis

143.6

15.4

3AA13

NOMESCO Finland

143.6

15.4

WXQ99

NOMESCO Finland

Other light therapy

14.6

15.3

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

7.3

15.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

15.1

672

4027

JG1CG

NOMESCO Finland

Extensive MRI of rectum

9.7

15.1

A06AD11

ATC

lactulose; oral

1.3

15.0

980

6278

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.6

15.0

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

4.6

14.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

14.9

2629

19054

-59

ICPC

Other therap proced/minor surg NEC

1.9

14.9

230

1045

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

4.1

14.8

123

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

40.1

14.8

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.1

14.6

216

L01BB05

ATC

fludarabine; systemic

+∞

14.6

C44.4

ICD-10 Finland

Malignant neoplasm: Skin of scalp and neck

+∞

14.6

L01CB01

ATC

etoposide; systemic

+∞

14.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

14.6

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

14.6

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

14.6

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

+∞

14.6

1501

Kela drug reimbursment

Palbociclib

+∞

14.6

1AA09

NOMESCO Finland

+∞

14.6

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

14.6

1512

Kela drug reimbursment

Ibrutinib

+∞

14.6

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

14.6

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

14.6

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

14.6

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

14.6

181

759

KDE20

NOMESCO Finland

Removal of foreign body from urethra

5.3

14.6

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

2.0

14.4

181

760

C44.69

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology

135.1

14.4

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

135.1

14.4

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

135.1

14.4

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

135.1

14.4

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.8

14.4

236

1096

S19

ICPC

Skin injury other

1.7

14.3

298

1490

H26.4

ICD-10 Finland

After-cataract

1.4

14.3

625

3736

ZX050

NOMESCO Finland

Stereotactic radiotherapy

8.2

14.2

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

8.2

14.2

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

32.1

14.1

WW409

NOMESCO Finland

Other aferesis

32.1

14.1

ZZS10

NOMESCO Finland

Transposition flap

32.1

14.1

D01AE16

ATC

amorolfine; topical

1.3

14.0

1109

7309

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

14.0

172

719

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

7.5

13.9

TKE10

NOMESCO Finland

Puncture of prostate

24.1

13.9

A07AA02

ATC

nystatin; oral

1.5

13.8

488

2791

R23.4

ICD-10 Finland

Changes in skin texture

2.7

13.8

307

D23.0

ICD-10 Finland

Benign neoplasm: Skin of lip

4.4

13.7

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

13.7

638

3857

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.3

13.7

100

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

5.0

13.7

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

47.9

13.7

329

Kela drug reimbursment

Lenalidomide

47.9

13.7

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

13.6

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

13.6

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

13.6

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

13.6

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

13.6

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

13.6

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

13.6

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

13.6

L02BA03

ATC

fulvestrant; parenteral

+∞

13.6

192

Kela drug reimbursment

Fulvestrant

+∞

13.6

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

13.6

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

13.6

L01XE01

ATC

[U] imatinib; oral

+∞

13.6

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

+∞

13.6

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

+∞

13.6

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

13.6

17331

ICD-8 Finland

Other malignant neoplasm of skin, Other and unspecified part of face

+∞

13.6

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

13.6

197

Kela drug reimbursment

Sunitinib

+∞

13.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

13.6

526

3067

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.9

13.6

247

J01MA14

ATC

moxifloxacin; systemic

1.4

13.5

706

4359

1XC07

NOMESCO Finland

67.6

13.5

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

7.5

13.5

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

126.7

13.5

KAC00

NOMESCO Finland

Nephrectomy

8.8

13.4

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

13.9

13.3

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.3

13.3

1XC02

NOMESCO Finland

3.8

13.3

128

ZXA10

NOMESCO Finland

Bilateral

1.2

13.2

1551

10749

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.9

13.2

193

864

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.9

13.2

237

A04AA03

ATC

tropisetron; systemic

35.9

13.0

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

8.2

12.9

S80

ICPC

Solar keratosis/sunburn

6.2

12.9

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

12.9

161

678

A06AH03

ATC

naloxegol; oral

4.8

12.8

S52

ICPC

Skin, Exc/remov/biopsy/destruc/debrid/caut

5.7

12.8

N05CF01

ATC

zopiclone; oral

1.2

12.8

2882

21320

KE1BG

NOMESCO Finland

MRI of prostate

4.9

12.7

8090/3-C44.8

ICD-O-3

Basal cell carcinoma, NOS, of overlapping lesion of skin

+∞

12.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

12.7

L01XE27

ATC

[U] ibrutinib; oral

+∞

12.7

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

12.7

394

Kela drug reimbursment

Palbociclib

+∞

12.7

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

12.7

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

12.7

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

12.7

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

12.7

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

12.7

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

12.7

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

12.7

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

12.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

12.7

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

12.7

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

12.7

L02BX03

ATC

abiraterone; oral

+∞

12.7

L57.9

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation, unspecified

7.1

12.6

G04BE01

ATC

alprostadil; parenteral, urethral

2.9

12.6

224

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

4.8

12.6

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

63.4

12.6

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

63.4

12.6

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

118.2

12.5

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

10.1

12.5

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.6

12.5

306

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.8

12.4

246

D05.0

ICD-10 Finland

Lobular carcinoma in situ

28.7

12.4

R4190

NOMESCO Finland

Nutritional therapy

1.9

12.3

177

785

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

3.7

12.3

120

Z71.8

ICD-10 Finland

Other specified counselling

1.2

12.3

1907

13621

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

12.2

339

1836

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

12.2

520

3094

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

8.8

12.1

D04.0

ICD-10 Finland

Carcinoma in situ: Skin of lip

17.8

12.1

N02AX02

ATC

tramadol; systemic, rectal

1.2

12.1

4043

30857

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

15.4

12.1

L01BB01

ATC

6.1

12.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

11.9

3015

22512

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

42.2

11.8

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

42.2

11.8

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

42.2

11.8

QAA10

NOMESCO Finland

Incision of skin of head or neck

6.1

11.8

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

11.8

491

2912

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.7

11.8

323

3989

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

19.0

11.7

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

11.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

11.7

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

11.7

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

11.7

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

11.7

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

11.7

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

11.7

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

11.7

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

11.7

CBD11

NOMESCO Finland

Opening of eylid graft or flap

+∞

11.7

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

11.7

C44.82

ICD-10 Finland

Overall spinocellular carcinoma of the skin

+∞

11.7

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

11.7

WW402

NOMESCO Finland

Leucoferesis

59.2

11.7

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.4

11.6

573

3503

G03CA04

ATC

estriol; systemic, vaginal

1.4

11.6

509

3046

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

109.8

11.6

1XC03

NOMESCO Finland

109.8

11.6

C44.12

ICD-10 Finland

Spinocellular carcinoma of the skin of the eyelids including the corner of the eye

109.8

11.6

KE1DR

NOMESCO Finland

Prostate metabolic PET with CT

109.8

11.6

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

109.8

11.6

S59

ICPC

Skin, Other therap proced/minor surg NEC

2.3

11.6

109

408

ZX108

NOMESCO Finland

Inhalation

3.3

11.5

149

M05BA04

ATC

alendronic acid; oral

1.4

11.5

648

4055

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

5.7

11.5

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

9.2

11.5

J02AC01

ATC

fluconazole; systemic

1.2

11.5

3764

28653

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.8

11.5

106

CBB99

NOMESCO Finland

Other excision or destruction of lesion of eyelid

3.9

11.5

102

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

11.5

1298

8950

X21

ICPC

Breast sympt/compl female other

2.2

11.4

117

454

HA1SA

NOMESCO Finland

Expansion mammography

9.7

11.4

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

11.4

261

1349

V03AE02

ATC

sevelamer; oral

3.3

11.4

151

ZZT00

NOMESCO Finland

Local skin and subcutaneous tissue flap

20.5

11.4

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

20.5

11.4

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.2

11.3

N07BB01

ATC

disulfiram; oral

0.6

11.2

152

2182

L21.0

ICD-10 Finland

Seborrhoea capitis

2.5

11.2

300

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

3.1

11.1

174

TJF80

NOMESCO Finland

Ostomy education

3.9

11.1

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

9.3

11.1

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

11.1

905

5991

D48

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other and unspecified sites

5.8

11.1

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

3.3

11.0

141

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

11.0

345

1927

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.7

11.0

240

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

39.4

11.0

C44.9

ICD-10 Finland

Malignant neoplasm: Malignant neoplasm of skin, unspecified

39.4

11.0

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

10.9

532

3247

5702

FHL

Local lymph node removal (eg armpit, groin)

15.2

10.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

10.9

190

905

A12BA01

ATC

potassium chloride; oral

1.6

10.9

294

1584

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

2.8

10.8

204

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

4.6

10.8

X77

ICPC

Malignant neopl genital female other

54.8

10.7

EBA00

NOMESCO Finland

Extraction of tooth

0.8

10.7

2294

22014

L01XE23

ATC

[U] dabrafenib; oral

+∞

10.7

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

10.7

4CJ01

NOMESCO Finland

+∞

10.7

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

10.7

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

+∞

10.7

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

10.7

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

+∞

10.7

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

10.7

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

10.7

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

10.7

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

10.7

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

10.7

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

10.7

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

10.7

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

10.7

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

+∞

10.7

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

10.7

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

10.7

159

Kela drug reimbursment

Pazopanib

+∞

10.7

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

10.7

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

10.7

316

Kela drug reimbursment

Imatinib

+∞

10.7

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

10.7

QAE35

NOMESCO Finland

Repair of skin defect in head or neck after surgery or injury

11.3

10.7

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

2.6

10.7

255

QBA10

NOMESCO Finland

Incision of skin of trunk

2.5

10.7

277

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.2

10.6

112

441

C44.92

ICD-10 Finland

Unspecified localization of spinocellular carcinoma of the skin

101.3

10.6

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

101.3

10.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

10.6

539

3317

L01AA02

ATC

chlorambucil; oral

12.3

10.6

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

4.8

10.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

10.5

4741

36851

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

19.3

10.5

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

13.8

10.5

WW200

NOMESCO Finland

Immunization

1.8

10.5

187

897

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

10.5

552

3415

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

5.8

10.4

B05DA

ATC

Isotonic solutions

2.7

10.4

225

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

10.3

145

640

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

10.3

1293

9016

GDC00

NOMESCO Finland

Lobectomy of lung

8.1

10.3

S99

ICPC

Skin disease other

1.9

10.3

147

654

M04AA01

ATC

allopurinol; systemic

1.3

10.3

898

5996

WW200

SPAT

0.8

10.3

575

6343

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.1

10.3

114

459

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.6

10.2

257

1360

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.2

10.2

136

C03CA01

ATC

furosemide; systemic

1.2

10.2

2009

14647

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

10.2

154

701

75310

ICD-8 Finland

Congenital anomalies of urinary system, Ren polycysticus bilateralis

21.1

10.2

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

10.2

175

833

H02AB04

ATC

methylprednisolone; systemic

1.2

10.1

1333

9341

H81

ICPC

Excessive ear wax

1.2

10.1

1314

9199

H91.1

ICD-10 Finland

Presbycusis

1.5

10.1

315

1760

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

10.1

2520

18748

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

6.8

10.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

10.0

304

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

10.0

968

6548

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

10.0

774

5088

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

8.9

10.0

SPAT1312

SPAT

General health counselling

1.2

9.9

2842

21368

ZX100

NOMESCO Finland

Oral

2.4

9.9

294

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

1.4

9.9

560

3513

D76

ICPC

Malignant neoplasm pancreas

50.7

9.8

QA6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in cheeks or nose

50.7

9.8

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

9.8

1613

11563

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.9

9.8

133

583

A59

ICPC

General and Unspecified, Other therap proced/minor surg NEC

2.6

9.8

228

RS220

NOMESCO Finland

2.4

9.8

306

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.3

9.8

693

4497

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

9.7

L04AX06

ATC

pomalidomide; oral

+∞

9.7

393

Kela drug reimbursment

Pomalidomide

+∞

9.7

L01EF01

ATC

palbociclib; oral

+∞

9.7

8092/3-C44.9

ICD-O-3

Infiltrating basal cell carcinoma, NOS, of skin, NOS

+∞

9.7

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

9.7

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

+∞

9.7

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

+∞

9.7

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

9.7

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

9.7

3012

Kela drug reimbursment

Cabozantinib

+∞

9.7

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

9.7

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

9.7

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

9.7

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

9.7

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

9.7

L01EA01

ATC

imatinib; oral (bcr-abl tyrosine kinase inhibitors)

+∞

9.7

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

9.7

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

9.7

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

9.7

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

+∞

9.7

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

9.7

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

+∞

9.7

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

9.7

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

+∞

9.7

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

9.7

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.7

1523

Kela drug reimbursment

+∞

9.7

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

+∞

9.7

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

9.7

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

9.7

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

9.7

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

9.7

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

9.7

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

+∞

9.7

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

+∞

9.7

3054

Kela drug reimbursment

+∞

9.7

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

9.7

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

9.7

L01EL01

ATC

ibrutinib; oral

+∞

9.7

1502

Kela drug reimbursment

Cabozantinib

+∞

9.7

L03AB05

ATC

interferon alfa-2b; parenteral

4.4

9.7

G04CB02

ATC

dutasteride; oral

1.5

9.7

369

2152

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

92.9

9.7

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

92.9

9.7

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

92.9

9.7

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

92.9

9.7

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

3.0

9.7

154

A02BC05

ATC

esomeprazole; systemic

1.1

9.6

4010

30952

205

Kela drug reimbursment

Chronic hypertension

1.2

9.6

2513

18752

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

4.3

9.6

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

4.7

9.5

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

9.5

1643

11829

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

4.0

9.5

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

1.8

9.5

165

788

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.6

9.5

216

L73.8

ICD-10 Finland

Other specified follicular disorders

2.6

9.4

223

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.5

9.4

1150

R60.0

ICD-10 Finland

Localized oedema

1.3

9.4

815

5441

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

13.5

9.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.1

9.3

3973

30704

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

3.4

9.2

110

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.4

9.2

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

2.3

9.2

293

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.4

9.2

888

WF099

NOMESCO Finland

Other radiotherapy

4.8

9.2

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

33.7

9.2

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.5

9.1

300

1700

ZXC10

NOMESCO Finland

Use of laser

1.7

9.1

174

857

J01FA10

ATC

azithromycin; systemic

1.1

9.1

5650

44687

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.4

9.0

356

2093

HA1BA

NOMESCO Finland

Extensive X-ray mammography

3.5

9.0

L04AA10

ATC

sirolimus; oral

12.3

9.0

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

9.0

5979

47472

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

46.4

8.9

D04

ICD-10 Finland

Carcinoma in situ of skin

14.1

8.9

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.3

8.9

905

6158

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

4.6

8.9

HA1DA

NOMESCO Finland

Restricted mammography

16.9

8.9

A10BA02

ATC

metformin; oral

0.9

8.9

2050

19595

C08CA01

ATC

amlodipine; oral

1.1

8.9

3351

25665

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.9

8.9

156

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.4

8.9

369

2190

S27

ICPC

Fear of skin disease other

2.9

8.8

152

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

8.8

1608

11638

ZZS55

NOMESCO Finland

Distension of tissue expander

+∞

8.8

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

8.8

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

8.8

L01BC59

ATC

trifluridine, combinations; systemic

+∞

8.8

QCA30

NOMESCO Finland

Electrocoagulation of skin of upper limb

+∞

8.8

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

8.8

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

+∞

8.8

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

+∞

8.8

198

Kela drug reimbursment

Sorafenib

+∞

8.8

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

8.8

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

8.8

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

8.8

8097/3-C44.5

ICD-O-3

Basal cell carcinoma, nodular of skin of trunk

+∞

8.8

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

+∞

8.8

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.8

1731A

ICD-9 Finland

Other malignant neoplasm of skin, Eyelid, including canthus[LUOMEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

8.8

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

8.8

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

+∞

8.8

1507

Kela drug reimbursment

Pomalidomide

+∞

8.8

8091/3-C44.5

ICD-O-3

Superficial basal cell carcinoma of skin of trunk

+∞

8.8

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

8.8

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

8.8

EJB40

NOMESCO Finland

Hemiglossectomy

+∞

8.8

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

8.8

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

8.8

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.6

8.8

221

1175

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

84.4

8.8

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

84.4

8.8

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

84.4

8.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.3

8.7

293

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

4.8

8.7

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

6.1

8.6

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

25.3

8.6

L71.9

ICD-10 Finland

Rosacea, unspecified

1.7

8.6

181

917

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

8.5

174

873

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

3.8

8.5

ICD-10 Finland

1.6

8.5

199

1038

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

9.6

8.5

A98

ICPC

Health maint/preventive medicine

1.2

8.5

11039

91558

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

3.5

8.5

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

8.5

235

1278

P15

ICPC

Chronic alcohol abuse

0.5

8.5

1193

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.4

8.4

456

2841

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

8.4

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

8.4

1375

9850

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

10.4

8.4

H02

ICPC

Hearing complaint

1.2

8.4

963

6653

J01AA04

ATC

lymecycline; systemic

1.2

8.3

990

6867

A97

ICPC

No disease

1.2

8.3

1138

8014

H00.1

ICD-10 Finland

Chalazion

1.5

8.2

266

1501

Z94.1

ICD-10 Finland

Heart transplant status

4.2

8.2

H02.1

ICD-10 Finland

Ectropion of eyelid

2.7

8.2

164

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.4

8.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.4

8.2

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

3.3

8.2

103

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.3

8.2

429

QAB05

NOMESCO Finland

Revision of wound of skin of head or neck

4.7

8.2

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

1.9

8.1

115

514

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

8.1

408

2512

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

3.6

8.1

C02EA02

ATC

1.5

8.1

286

1647

L85.3

ICD-10 Finland

Xerosis cutis

2.3

8.0

260

D18.0

ICD-10 Finland

Haemangioma, any site

1.7

8.0

176

903

Z01.8

ICD-10 Finland

Other specified special examinations

1.2

8.0

1856

13698

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

2.9

8.0

137

B05DB

ATC

Hypertonic solutions

2.6

8.0

182

4194

NOMESCO Finland

42.2

8.0

N64.5

ICD-10 Finland

Other signs and symptoms in breast

1.8

8.0

144

696

V03AE01

ATC

polystyrene sulfonate; oral

2.2

8.0

317

C08CA02

ATC

felodipine; oral

1.3

8.0

723

4857

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

3.2

8.0

110

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.5

8.0

276

1584

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

7.0

7.9

Z93.3

ICD-10 Finland

Colostomy status

3.7

7.9

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.7

7.9

N05AX08

ATC

risperidone; systemic

0.7

7.9

268

3181

Y06

ICPC

Prostate symptom/complaint

1.7

7.9

164

829

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

5.6

7.9

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

7.8

116

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

2.9

7.8

129

C44.79

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including hip or other unspecified histology

76.0

7.8

WXQ40

NOMESCO Finland

Photodynamic therapy of broad area

76.0

7.8

C44.7

ICD-10 Finland

Malignant neoplasm: Skin of lower limb, including hip

76.0

7.8

G04BE30

ATC

drugs used in erectile dysfunction - combinations

76.0

7.8

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

76.0

7.8

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

7.8

1378

9935

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

+∞

7.8

1CD01

NOMESCO Finland

+∞

7.8

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

7.8

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

7.8

C02.2

ICD-10 Finland

Malignant neoplasm: Ventral surface of tongue

+∞

7.8

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

7.8

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

7.8

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

7.8

20298

ICD-8 Finland

Other neoplasms of lymphoid tissue, Lymphomata alia

+∞

7.8

L01XE11

ATC

[U] pazopanib; oral

+∞

7.8

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

7.8

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

7.8

C739

ICD-10 Finland

+∞

7.8

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

7.8

L01XE04

ATC

[U] sunitinib; oral

+∞

7.8

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

7.8

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

7.8

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

7.8

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

7.8

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

+∞

7.8

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

7.8

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.8

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

7.8

L01XX52

ATC

venetoclax; oral

+∞

7.8

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

7.8

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

7.8

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

7.8

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

+∞

7.8

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

7.8

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

7.8

8097/3-C44.4

ICD-O-3

Basal cell carcinoma, nodular of skin of scalp and neck

+∞

7.8

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

7.8

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

7.8

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

7.8

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

7.8

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

7.8

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

7.8

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

7.8

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

7.8

C34.02

ICD-10 Finland

Malignant tumor of the main bronchial adenocarcinoma

+∞

7.8

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

+∞

7.8

399

Kela drug reimbursment

Venetoclax

+∞

7.8

M05BA02

ATC

clodronic acid; systemic

23.2

7.8

KE1CG

NOMESCO Finland

Extensive MRI of prostate

4.6

7.8

X26

ICPC

Fear of breast cancer female

3.0

7.8

124

SPAT1361

SPAT

Collection of tissue sample

2.7

7.7

156

P72

ICPC

Schizophrenia

0.4

7.7

750

N18.8

ICD-10 Finland

Other chronic renal failure

1.7

7.7

169

867

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.3

7.7

562

3667

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.1

7.7

362

9703

FHL

Breast resection

2.6

7.7

177

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.9

7.6

113

513

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.4

7.6

233

Z00.0

ICD-10 Finland

General medical examination

1.2

7.6

1509

10989

H26.3

ICD-10 Finland

Drug-induced cataract

2.4

7.6

209

G04CA01

ATC

alfuzosin; oral

1.2

7.6

815

5586

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

7.6

1620

11878

D07AB08

ATC

desonide; topical

1.3

7.6

769

5238

N05CB02

ATC

barbiturates in combination with other drugs

1.6

7.6

186

987

H13

ICPC

Plugged feeling ear

1.2

7.5

1483

10797

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

7.5

1416

10267

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

5.3

7.5

103

Kela drug reimbursment

Diabetes, insulin-treated

0.9

7.5

1967

18646

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.2

7.4

879

6092

N64.9

ICD-10 Finland

Disorder of breast, unspecified

2.3

7.4

239

1XX32

NOMESCO Finland

28.1

7.4

JJB10

NOMESCO Finland

Atypcal resection of liver

28.1

7.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

7.4

1587

11637

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

7.4

331

1998

XQ902

NOMESCO Finland

Other photography

2.8

7.4

136

F10.20

ICD-10 Finland

Alcohol dependence currently independent

0.5

7.4

915

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

5.2

7.4

-60

ICPC

Result test/procedure

1.4

7.3

423

2664

XCK10

NOMESCO Finland

Photography of fundus of eye

1.2

7.3

788

5400

OAB42

NOMESCO Finland

Guidance related to known health problem

6.2

7.3

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

6.2

7.3

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

7.3

947

6624

R84

ICPC

Malignant neoplasm bronchus/lung

18.6

7.3

CBB35

NOMESCO Finland

Cryotherapy of lesion of eyelid

18.6

7.3

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

2.2

7.3

281

H00.00

ICD-10 Finland

Hordeolum

1.5

7.3

273

1596

JAL00

NOMESCO Finland

Biopsy of peritoneum

4.4

7.2

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.9

7.2

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.6

7.2

168

M01AX05

ATC

glucosamine; oral

1.2

7.2

1986

14848

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

2.7

7.2

142

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

2.7

7.2

148

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.2

7.2

828

5723

C10AA03

ATC

pravastatin; oral

1.3

7.2

563

3712

HAD40

NOMESCO Finland

Mastopexy

4.7

7.2

1CX01

NOMESCO Finland

5.9

7.1

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

7.1

990

6974

J01MA06

ATC

norfloxacin; oral

1.2

7.1

1151

8232

KAC20

NOMESCO Finland

Nephroureterectomy

38.0

7.1

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

38.0

7.1

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.0

7.1

F10.25

ICD-10 Finland

Alcohol dependence continuous use

0.5

7.1

749

4056

NOMESCO Finland

6.3

7.1

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.7

7.1

136

674

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

11.0

7.1

D07AC01

ATC

betamethasone; topical

1.1

7.1

3164

24429

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

4.9

7.1

N05AH03

ATC

olanzapine; systemic

0.7

7.0

215

2595

S06

ICPC

Rash localized

1.3

7.0

414

2618

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.6

7.0

151

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

2.9

7.0

115

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

7.0

1185

8514

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.9

7.0

1859

17622

C10AA04

ATC

fluvastatin; oral

1.3

7.0

676

4581

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

9.1

6.9

EAA30

NOMESCO Finland

Partial excision of lower lip

21.1

6.9

H75

ICPC

Neoplasm of ear

21.1

6.9

D77

ICPC

Malignant digestive neopl other/NOS

21.1

6.9

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

21.1

6.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

6.9

538

3544

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.6

6.9

163

857

BAA60

NOMESCO Finland

Total thyroidectomy

1.7

6.9

148

759

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.6

6.9

156

Z93.2

ICD-10 Finland

Ileostomy status

3.8

6.9

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

67.6

6.9

N30.4

ICD-10 Finland

Irradiation cystitis

67.6

6.9

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

67.6

6.9

C16.00

ICD-10 Finland

Cardia

67.6

6.9

Z94.4

ICD-10 Finland

Liver transplant status

3.3

6.9

D18

ICPC

Change in faeces/bowel movements

1.7

6.9

134

669

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.8

6.8

103

474

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

+∞

6.8

8093/3-C44.9

ICD-O-3

Basal cell carcinoma, fibroepithelial of skin, NOS

+∞

6.8

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

6.8

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

6.8

L01XE33

ATC

[U] palbociclib; oral

+∞

6.8

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

6.8

L01EX07

ATC

cabozantinib; oral

+∞

6.8

8743/3-C44.6

ICD-O-3

Low cumulative sun damage melanoma of skin of upper limb and shoulder

+∞

6.8

1BA04

NOMESCO Finland

+∞

6.8

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

6.8

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

6.8

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

+∞

6.8

L01BC53

ATC

tegafur, combinations; systemic

+∞

6.8

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

6.8

322

Kela drug reimbursment

Sunitinib

+∞

6.8

L01XE13

ATC

[U] afatinib; oral

+∞

6.8

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

6.8

C45.0

ICD-10 Finland

Mesothelioma of pleura

+∞

6.8

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

6.8

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.8

18099

ICD-8 Finland

Malignant neoplasm of cervix uteri

+∞

6.8

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

6.8

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

6.8

C441, 8097, 3

ICD-O-3

+∞

6.8

L01XE25

ATC

[U] trametinib; oral

+∞

6.8

9650/3-C77.1

ICD-O-3

Hodgkin lymphoma, NOS, of intrathoracic lymph nodes

+∞

6.8

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

+∞

6.8

L02BA02

ATC

toremifene; oral

+∞

6.8

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

6.8

L01XX28

ATC

[D] imatinib; oral

+∞

6.8

8720/3-C44.2

ICD-O-3

Malignant melanoma, NOS, of external ear

+∞

6.8

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

6.8

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

+∞

6.8

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.8

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

+∞

6.8

341

Kela drug reimbursment

Afatinib and gefitinib

+∞

6.8

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

6.8

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

6.8

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

6.8

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

6.8

C43.29

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology

+∞

6.8

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.8

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

6.8

U75

ICPC

Malignant neoplasm of kidney

+∞

6.8

DHB01

NOMESCO Finland

Partial excision of external nose

+∞

6.8

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.5

6.8

797

L85.89

ICD-10 Finland

Other specified epidermal thickening

3.6

6.8

SPAT1193

SPAT

Pap smear

0.7

6.8

326

3668

9733

FHL

Excision of skin change in operating room or anesthesia

1.8

6.8

102

467

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

6.8

405

4426

WVA20

NOMESCO Finland

Medicine administration

1.7

6.8

128

633

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

10.0

6.8

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.3

6.7

587

3927

WX892

NOMESCO Finland

Monitored bed care

1.3

6.7

505

3313

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.6

6.7

167

893

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.6

6.7

154

807

H61.2

ICD-10 Finland

Impacted cerumen

1.3

6.7

416

2657

JAH00

NOMESCO Finland

Laparotomy

1.7

6.6

137

695

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

3.0

6.6

102

N05AA02

ATC

levomepromazine; systemic

0.7

6.6

170

2117

N04AA02

ATC

biperiden; systemic

0.5

6.6

918

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

25.3

6.6

KCC10

NOMESCO Finland

Cystoprostatectomy

25.3

6.6

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.2

6.6

691

4727

D22.1

ICD-10 Finland

Melanocytic naevi of eyelid, including canthus

2.8

6.5

122

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

13.3

6.5

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

13.3

6.5

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.3

6.5

473

3090

QCE99

SPAT

3.8

6.5

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

16.9

6.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

6.5

480

3144

N05AF03

ATC

chlorprothixene; systemic

0.6

6.5

1274

KFC00

NOMESCO Finland

Unilateral orchiectomy

4.1

6.5

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.5

6.5

191

1061

Z10.0

ICD-10 Finland

Occupational health examination

0.7

6.5

176

2166

L04AA05

ATC

[U] tacrolimus; systemic

5.2

6.5

SPAT1002

SPAT

Excision or drainage of chalazion

2.0

6.5

325

B02

ICD-10 Finland

Zoster [herpes zoster]

1.4

6.4

265

1576

D01BA02

ATC

terbinafine; oral; topical

1.1

6.4

2373

18083

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

6.4

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

7.9

6.4

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

1.6

6.4

164

879

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

1.9

6.4

373

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

2.9

6.4

108

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

6.4

552

3690

SPAT1109

SPAT

Analgesia with portable analgesic pump

5.4

6.4

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

1.5

6.4

199

1119

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.7

6.4

129

651

UDC00

NOMESCO Finland

Ear microscopy

1.3

6.3

535

3565

B01AA03

ATC

warfarin; systemic

1.2

6.3

1378

10118

A01AB09

ATC

miconazole; local oral

1.2

6.3

679

4663

L72.0

ICD-10 Finland

Epidermal cyst

1.9

6.3

348

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.0

6.3

325

N05AA01

ATC

chlorpromazine; systemic, rectal

0.4

6.2

622

T71

ICPC

Malignant neoplasm thyroid

33.7

6.2

D74

ICPC

Malignant neoplasm stomach

33.7

6.2

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

4.4

6.2

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

6.2

3883

30502

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

1.4

6.2

350

2200

ZXC12

NOMESCO Finland

Pulse colorlaser

3.2

6.2

Z43.3

ICD-10 Finland

Attention to colostomy

7.4

6.2

G04BD12

ATC

mirabegron; oral

1.2

6.2

773

5392

5602

FHL

Internal fistula (eg Cimino)

11.6

6.2

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

6.2

952

6780

196

Kela drug reimbursment

Paricalcitol and cinacalcet

2.6

6.2

137

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

6.2

1084

7812

N05AF05

ATC

zuclopenthixol; systemic

0.4

6.2

470

P99

ICPC

Psychological disorders other

0.6

6.2

999

D10BA01

ATC

isotretinoin; oral

1.4

6.2

271

1636

JLC30

NOMESCO Finland

Pancreatoduodenectomy

4.9

6.2

WX320

NOMESCO Finland

Spinalanesthesy

1.1

6.2

1993

15059

SPAT1283

SPAT

Restricted health certificate

0.8

6.2

693

7048

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

3.4

6.1

A02BA02

ATC

ranitidine; systemic

1.1

6.1

1713

12809

JAB00

NOMESCO Finland

Division and ligature of inguinal hernia sac

5.5

6.1

-44

ICPC

Preventive immunization/medic

1.3

6.1

574

3876

B01AB04

ATC

dalteparin; parenteral

1.4

6.1

283

1724

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

4.3

6.1

KFC10

NOMESCO Finland

Bilateral orchiectomy

19.0

6.1

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.5

6.1

197

1119

U13

ICPC

Bladder symptom/complaint other

1.5

6.1

194

1099

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

5.9

6.1

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

1.8

6.1

437

Z01.2

ICD-10 Finland

Dental examination

1.1

6.0

3750

29444

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.4

6.0

307

1900

C07AB03

ATC

atenolol; systemic

1.3

6.0

408

2641

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

7441

10143

6.93

307.65

1.6

1.1

—

(4035726)

2629

3818

5.22

307.65

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2697

7370

2.72

307.65

3.7

1.5

ug/l

13.5

8.7

0.83

2201

5570

(40768443) Skin Pathology biopsy report

2171

5403

2.95

307.65

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

15125

41798

5.16

307.65

3.3

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

370

203

12.76

304.74

2.6

1.1

u/ml

28.3

29.2

0.04

357

186

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11853

62654

1.61

258.06

6.2

3.8

umol/l

12.1

11.9

0.79

11147

58432

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

17025

98568

1.68

255.98

8.2

5.5

u/l

79.9

76.3

14.41

15825

90815

(3024561) Albumin [Mass/volume] in Serum or Plasma

10570

54688

1.60

247.65

5.0

3.8

g/l

34.8

35.5

23.66

9662

49737

(3013650) Neutrophils [#/volume] in Blood by Automated count

12550

67974

1.58

239.06

9.3

6.4

e9/l

4.1

4.3

8.18

10863

57866

(3015377) Calcium [Moles/volume] in Serum or Plasma

8377

41206

1.62

238.95

3.4

2.1

mmol/l

2.4

0.37

7082

34028

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3338

12742

1.94

227.87

4.5

2.7

u/l

247.0

241.9

1.05

3152

11780

(40768800) Prostate Pathology biopsy report

584

839

4.90

227.76

1.2

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11215

59808

1.56

221.75

6.3

5.3

mmol/l

1.2

0.64

10009

52792

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12119

66162

1.54

211.83

7.2

5.7

mmol/l

1.2

0.20

10121

55396

(1617658) Protocol used for examination of sentinel lymph nodes

157

64.12

205.81

1.1

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

14921

85874

1.54

198.66

5.3

4.5

e6/l

969.1

1633.2

0.98

171

1298

(40768793) Breast Pathology biopsy report

519

761

4.79

197.78

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

7277

36051

1.57

190.65

2.7

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10230

54672

1.51

189.16

4.2

3.7

—

(3023368) Bacteria identified in Blood by Culture

6919

34262

1.56

179.15

4.5

3.9

—

(3032080) INR in Blood by Coagulation assay

10126

54871

1.48

167.99

11.2

9.9

inr

1.4

1.3

1.27

2796

15040

(40758558) Short blood count panel - Blood

5938

28743

1.57

167.72

7.1

4.8

—

(3018418) pH of Serum or Plasma

7513

38501

1.51

162.48

4.7

3.3

7.4

0.79

1348

6666

(3030467) Casts [#/volume] in Urine by Automated count

7061

35778

1.52

160.72

3.7

3.0

e6/l

0.4

0.5

0.77

5410

26651

(36304419) Bacteria [Presence] in Urine

6811

34331

1.52

158.39

3.6

2.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

210

143

10.21

152.87

3.0

1.1

u/ml

45.5

22.1

1.35

204

132

(40768795) Lymph node Pathology biopsy report

269

260

7.21

152.67

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5659

27684

1.54

149.42

2.5

2.2

—

(3002582) Erythrocytes [#/volume] in Urine

7485

38872

1.48

148.38

3.8

3.1

e6/l

93.8

93.9

0.00

5769

29454

(3033658) Prothrombin time (PT) actual/Normal

6064

30247

1.51

145.69

4.2

3.5

85.1

87.4

8.96

5940

29393

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4963

23711

1.56

144.95

3.2

2.2

mmol/l

2.5

4.38

4291

20144

(3018095) Leukocytes [#/volume] in Urine

8518

45546

1.45

144.35

4.3

3.5

e6/l

101.7

116.5

0.70

6198

31929

(42870588) Differential panel, method unspecified - Blood

7905

41982

1.45

136.85

6.5

5.4

—

(3006315) Basophils [#/volume] in Blood

10978

62202

1.41

130.67

6.4

5.5

e9/l

0.0

4.41

9354

53005

(3013826) Glucose [Moles/volume] in Serum or Plasma

13213

77337

1.40

129.93

4.8

4.4

mmol/l

6.7

6.8

6.59

12497

72074

(3001604) Monocytes [#/volume] in Blood

10914

61822

1.40

129.78

6.4

5.4

e9/l

0.6

0.20

9296

52640

(3000850) Epithelial cells [#/volume] in Urine

5438

27061

1.50

129.37

2.9

2.5

e6/l

4.5

5.2

4.76

4708

23364

(3026782) Osmolality of Urine

5089

25023

1.51

127.96

3.2

2.7

mosm/kgh2o

543.7

542.9

0.10

4288

20855

(3019198) Lymphocytes [#/volume] in Blood

11124

63412

1.40

126.02

6.5

5.5

e9/l

2.0

1.9

4.16

9633

55026

(3013115) Eosinophils [#/volume] in Blood

11238

64229

1.39

124.94

6.6

5.6

e9/l

0.2

10.09

9711

55539

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

20134

127971

1.58

123.70

18.1

13.5

mg/l

26.2

23.8

16.01

16321

100397

(3037467) Urinalysis macro (dipstick) panel - Urine

15028

90358

1.40

122.66

5.0

4.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

201

180

7.76

121.18

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

927

2725

2.40

119.55

3.1

2.0

u/ml

3349.6

134.1

0.60

787

2205

(3019069) Monocytes/100 leukocytes in Blood

10190

57580

1.39

119.07

7.1

6.0

8.8

8.7

2.23

9406

53067

(3006504) Eosinophils/100 leukocytes in Blood

10121

57303

1.38

115.66

6.8

5.7

2.8

3.0

14.44

9319

52577

(3022096) Basophils/100 leukocytes in Blood

9871

55692

1.38

115.01

6.8

5.7

0.7

3.05

9081

51143

(3002030) Lymphocytes/100 leukocytes in Blood

10345

58833

1.38

114.70

7.0

5.8

26.8

27.4

5.15

9496

53879

(3026008) Bacteria identified in Urine by Culture

7615

41167

1.41

114.03

3.6

3.2

—

(3018010) Neutrophils/100 leukocytes in Blood

10207

58151

1.37

110.40

6.7

5.6

58.2

57.6

4.86

9402

53540

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8449

46774

1.38

108.45

5.8

4.0

ug/l

3.4

2.4

4.77

7408

41813

(3027945) Reticulocytes/100 erythrocytes in Blood

3254

14965

1.58

108.42

2.6

2.1

1.8

0.04

2821

12943

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6328

33371

1.42

107.69

2.4

2.3

mg/l

3.1

3.0

2.88

5297

28180

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3908

18801

1.52

106.26

3.2

2.5

mmol/l

0.8

2.15

3582

17103

(3019550) Sodium [Moles/volume] in Serum or Plasma

21119

136756

1.61

104.04

21.5

16.3

mmol/l

139.7

139.8

6.93

20619

132829

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

120

13.63

102.72

1.3

1.1

ug/l

1.8

2.8

0.53

(3023103) Potassium [Moles/volume] in Serum or Plasma

21145

137081

1.61

101.71

21.7

16.4

mmol/l

4.0

0.37

20613

132922

(3049717) Cytology report of Urine Cyto stain

1263

4497

1.99

101.40

2.8

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2250

9670

1.67

97.80

2.2

2.0

g/l

0.2

0.23

2072

8741

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8008

44514

1.36

97.18

3.1

ng/l

1832.9

1521.9

6.04

6902

38188

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4102

20288

1.48

96.45

3.4

2.7

e6/l

2.0

2.9

6.04

2276

10917

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4462

22452

1.46

96.01

3.1

2.6

e6/l

1.1

1.2

0.99

2610

12982

(3023520) Reticulocytes [#/volume] in Blood

2515

11214

1.61

94.37

2.8

2.2

e9/l

68.0

69.4

1.09

1881

8531

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4223

21113

1.46

93.65

1.9

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5027

25966

1.43

93.65

3.5

2.8

ug/l

0.8

0.7

6.95

3692

18037

(3021589) Normoblasts [#/volume] in Blood

9623

55390

1.33

90.95

11.3

8.7

e9/l

0.0

0.05

7882

45295

(3020564) Creatinine [Moles/volume] in Serum or Plasma

21132

137657

1.56

88.43

21.5

15.8

umol/l

84.2

79.5

49.14

21119

137596

(3044889) 12 lead EKG panel

15282

94225

1.34

88.26

4.6

4.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21102

137579

1.54

85.40

12.2

9.5

u/l

24.3

25.4

11.63

20118

131188

(40761511) CBC panel - Blood by Automated count

20472

132671

1.48

84.66

17.2

13.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6775

37296

1.35

84.52

5.0

3.9

22.3

24.2

20.40

3688

18370

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3329

16212

1.48

83.24

6.8

5.3

mmol/l

1.0

0.02

3054

14859

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

19089

122216

1.40

83.15

17.5

12.5

ml/min/173m2

72.2

75.7

108.94

16075

98245

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10270

60271

1.31

81.37

2.2

2.0

pmol/l

95.3

95.5

0.14

5178

30221

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3559

17651

1.46

80.92

2.9

2.6

21.8

22.4

1.76

3028

14708

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8809

50710

1.32

79.71

3.1

2.8

ug/l

154.4

133.2

4.64

7917

46132

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3754

18888

1.44

78.91

2.8

2.5

g/l

2.3

7.37

3431

17236

(3013707) Erythrocyte sedimentation rate by Westergren method

15786

98440

1.32

78.73

4.5

4.3

mm/h

13.8

12.7

14.12

14288

90225

(3007853) Bacteria identified in Skin by Aerobe culture

3037

14703

1.49

77.72

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

4017

20544

1.42

76.99

2.8

2.5

umol/l

12.2

12.8

5.75

3667

18744

(3014576) Chloride [Moles/volume] in Serum or Plasma

3239

15969

1.46

75.43

6.5

mmol/l

104.5

104.2

2.30

3185

15554

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9345

54590

1.30

74.17

2.3

2.2

nmol/l

82.0

79.3

14.92

8101

47662

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

599

1795

2.34

73.83

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

21585

142064

1.55

73.81

27.2

20.1

g/l

132.7

135.6

146.78

21234

139247

(3024731) MCV [Entitic volume]

21582

142042

1.55

73.77

27.0

19.9

91.8

91.5

22.36

21239

139207

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

121

107

7.83

73.75

6.0

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

21582

142050

1.55

73.62

27.1

19.9

e12/l

4.4

4.5

121.31

20885

136576

(3007461) Platelets [#/volume] in Blood

21573

141985

1.55

73.48

27.1

19.9

e9/l

239.0

246.4

48.95

20948

137125

(3035941) MCH [Entitic mass]

21577

142023

1.55

73.37

26.9

19.9

30.4

1.10

21234

139196

(3010813) Leukocytes [#/volume] in Blood

21581

142061

1.55

73.26

27.1

20.0

e9/l

6.9

6.7

6.68

20886

136607

(3042936) Bacteria identified in Isolate by Culture

3431

17277

1.43

71.02

2.0

2.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

6119

33916

1.33

70.04

1.6

1.5

nmol/l

21.0

20.6

1.00

5118

28459

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2967

14663

1.45

67.61

1.8

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

13.18

67.41

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2351

11127

1.51

66.42

2.7

1.6

g/l

65.8

66.8

6.84

2103

9891

(3019309) Folate [Moles/volume] in Red Blood Cells

5276

28804

1.34

66.29

1.8

nmol/l

1176.4

1163.6

0.43

3810

21458

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1450

6140

1.67

65.65

1.8

1.6

g/l

1.5

1.6

3.09

1233

5202

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

529

1583

2.33

65.42

2.8

1.9

u/ml

729.9

714.1

0.01

474

1420

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2683

13117

1.46

64.43

3.7

3.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2942

14659

1.44

63.89

1.9

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

2349

11211

1.49

63.58

8.2

7.0

mmol/l

11.1

10.9

0.77

2219

10577

(3022217) INR in Platelet poor plasma by Coagulation assay

3831

20103

1.38

61.51

32.6

28.1

inr

1.5

1.4

0.59

398

2686

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1929

8893

1.54

61.31

1.6

—

(3000991) Gas panel - Venous blood

2187

10375

1.50

60.80

7.2

8.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

240

485

3.44

60.62

1.2

1.5

ug/l

6.7

9.7

1.91

228

421

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3825

20122

1.37

60.33

2.0

1.9

30.2

29.9

1.15

3719

19489

(3002385) Erythrocyte distribution width [Ratio]

16273

103424

1.27

58.22

22.4

16.2

13.9

13.7

32.28

15921

100754

(3010375) cycloSPORINE [Mass/volume] in Blood

223

449

3.45

56.67

32.3

27.6

ug/l

96.9

115.1

5.07

203

370

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2187

10524

1.48

56.47

4.2

3.7

ng/l

100.1

92.6

2.30

1853

8849

(3014111) Lactate [Moles/volume] in Serum or Plasma

2265

11033

1.46

54.88

6.0

6.7

mmol/l

1.4

0.75

2189

10607

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18602

120570

1.30

54.41

5.0

4.8

mu/l

2.2

2.1

0.31

16603

108860

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2603

13069

1.42

53.52

3.0

2.2

umol/l

7.7

7.8

0.09

2246

11170

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

997

4033

1.74

53.15

2.5

3.1

u/ml

0.4

0.25

551

2392

(3042111) Morphology [Interpretation] in Bone marrow Narrative

492

1573

2.18

52.15

1.5

1.3

—

(3022145) Colonoscopy Study observation

2673

13545

1.41

52.06

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

17403

112040

1.27

51.92

20.0

15.0

38.8

39.3

7.87

10962

72666

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2195

10736

1.45

51.91

2.5

2.2

u/l

44.6

42.5

0.07

1878

9045

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

284

701

2.82

51.80

1.7

1.3

ug/l

26.5

24.0

0.16

278

679

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

533

1769

2.10

51.44

6.1

5.7

iu/ml

1022.9

929.2

0.06

266

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1690

7881

1.52

50.59

1.7

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

633

2259

1.96

50.18

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9120

54829

1.24

50.03

4.2

3.8

ng/l

83.2

77.1

0.05

6989

39660

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

19797

129850

1.32

48.78

5.3

5.0

mmol/l

6.0

9.14

17580

117217

(3003434) Protein [Mass/volume] in Pleural fluid

455

1455

2.18

48.23

1.4

1.5

g/l

31.4

29.8

1.81

395

1274

(3009261) Glucose [Presence] in Urine by Test strip

10656

65309

1.23

48.06

4.3

3.9

estimate

0.0

0.04

1994

10867

(3045142) Bone marrow Pathology biopsy report

325

899

2.51

47.66

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

10532

64515

1.23

47.54

5.6

5.1

estimate

0.0

1.60

2028

11157

(3035350) Ketones [Presence] in Urine by Test strip

10525

64492

1.23

47.26

4.3

3.8

estimate

0.0

0.50

2014

10960

(3026493) Urate [Moles/volume] in Serum or Plasma

6227

36073

1.26

46.70

3.1

2.5

umol/l

5811.8

5640.0

0.10

5225

30519

(40768806) Pleura Pathology biopsy report

350

1017

2.39

46.28

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

983

4140

1.67

45.16

2.6

2.9

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

231

549

2.92

45.12

1.7

1.4

mg/l

4.3

3.9

0.64

215

521

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

419

1341

2.18

44.35

3.0

2.6

u/ml

344.8

7653.0

0.53

(3015736) pH of Urine

8390

50447

1.23

44.22

4.0

3.6

6.1

5.3

2.13

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

266

693

2.67

43.96

3.2

1.6

nmol/l

6.7

4.5

0.71

258

659

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

714

2786

1.79

43.01

1.9

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1960

9723

1.43

42.56

2.6

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

967

4139

1.64

41.70

3.6

1.5

u/ml

62.1

29.0

3.14

929

3925

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4851

27590

1.27

41.62

4.1

4.0

ng/l

327.1

553.9

5.65

4191

22612

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1418

6634

1.50

41.58

2.1

nmol/l

12.3

14.6

18.11

1225

5763

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1636

7916

1.46

40.53

7.6

8.9

0.7

0.93

1631

7863

(3027801) Oxygen [Partial pressure] in Arterial blood

2819

14984

1.34

40.02

6.2

6.9

kpa

12.2

11.6

6.53

2687

14246

(21494815) CD4 cells/100 lymphocytes in Specimen

221

549

2.79

39.96

1.8

2.0

36.6

44.8

1.69

(3012441) Differential panel - Pleural fluid

350

1087

2.24

39.87

1.4

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2819

14994

1.34

39.83

6.2

6.9

kpa

5.0

5.1

0.52

2685

14264

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6901

41026

1.23

39.34

2.6

2.3

u/l

59.5

60.1

0.20

6259

37314

(3017181) Myelocytes/100 leukocytes in Blood

1997

10095

1.40

38.81

4.4

3.7

1.0

0.8

2.39

584

2117

(3013512) EKG study

7010

41805

1.22

38.57

4.5

4.1

—

(3003396) Base excess in Arterial blood by calculation

2802

14957

1.33

38.54

6.2

6.9

mmol/l

0.9

1.3

6.19

2197

11652

(3011412) CD3 cells [#/volume] in Blood

243

653

2.58

37.88

2.1

2.0

e9/l

1.1

1.0

0.75

141

347

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1468

7086

1.46

36.74

6.1

7.2

mmol/l

24.7

24.9

0.96

1461

7005

(3037756) Immunofixation for Serum or Plasma

669

2686

1.74

36.59

1.6

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

183

432

2.94

36.27

1.8

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

358

1171

2.13

35.98

1.4

1.5

e6/l

70794.3

59225.4

0.26

201

705

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

312

967

2.24

35.77

1.3

u/l

477.4

412.0

0.19

296

899

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2315

12143

1.35

35.64

6.8

7.7

g/l

119.7

122.3

7.23

2237

11685

(3036782) Glucose [Moles/volume] in Pleural fluid

313

973

2.24

35.63

1.3

mmol/l

6.1

6.7

2.99

289

891

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

204

520

2.72

35.24

2.3

2.1

e6/l

592.5

930.8

1.04

248

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1010

4552

1.55

35.09

2.8

1.5

g/l

1.2

0.5

5.66

854

3835

(3023199) Leukocytes [#/volume] in Pleural fluid

385

1308

2.05

35.07

1.4

1.5

e6/l

2171.0

3499.5

0.82

257

959

(3021440) Promyelocytes/100 leukocytes in Blood

1907

9731

1.38

34.90

4.4

3.8

0.1

1.30

548

1976

(3000494) Fungus identified in Specimen by Culture

2766

14957

1.31

34.45

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

20089

133242

1.27

33.65

5.6

5.5

mmol/l

2.6

2.7

42.52

18002

121774

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1357

6576

1.45

33.20

7.9

9.0

mmol/l

24.3

24.5

1.77

1259

5964

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1244

5941

1.47

32.82

3.8

4.1

mmol/l

24.1

24.2

0.59

1125

5241

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2023

10522

1.36

32.78

4.3

3.0

mmol/l

1.2

0.45

1729

8851

(3016502) Oxygen saturation in Arterial blood

2510

13481

1.32

32.71

6.4

7.2

95.7

95.1

4.00

2424

12961

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15435

99813

1.19

32.67

4.0

pmol/l

15.1

15.0

6.07

13641

89382

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

157

363

3.00

32.30

2.7

2.5

36.0

43.2

1.72

133

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

18972

125154

1.23

32.28

6.5

6.4

mmol/mol

40.1

40.6

8.93

17105

114674

(3045788) Cell count panel - Pleural fluid

309

998

2.15

32.11

1.4

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

163

387

2.92

32.05

4.9

1.2

u/ml

132.6

315.6

1.20

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

965

4405

1.53

31.65

3.6

1.6

mg/l

46.6

37.9

1.22

794

3555

(3034860) Kappa light chains.free [Mass/volume] in Serum

966

4421

1.53

31.30

3.6

1.6

mg/l

122.7

47.1

0.71

793

3573

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1481

7375

1.41

31.18

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1801

9273

1.37

31.06

4.3

3.6

0.6

0.24

431

1572

(3025159) Blasts/100 leukocytes in Blood

1797

9257

1.37

30.89

4.4

3.8

0.1

0.2

0.45

465

1723

(3004809) Band form neutrophils/100 leukocytes in Blood

419

1536

1.90

30.83

4.2

2.9

1.5

1.3

0.59

339

1155

(1175426) CD3 cells/100 lymphocytes in Blood

182

471

2.68

30.63

1.6

1.9

70.4

71.7

0.42

169

446

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

935

4275

1.53

30.43

3.6

1.6

ratio

6.1

2.1

1.09

339

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

670

2847

1.64

29.75

3.6

2.7

mg/l

1.8

1.7

1.49

601

2523

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

246

747

2.28

29.67

1.2

1.3

u/l

15.8

12.5

0.99

230

673

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1143

5476

1.46

29.65

2.6

1.4

g/l

7.4

7.5

1.36

844

4002

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

930

4275

1.52

29.53

2.5

1.4

g/l

37.3

37.5

0.38

780

3585

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1079

5118

1.48

29.44

2.6

1.4

g/l

3.1

0.35

832

3940

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1140

5471

1.46

29.31

2.6

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

176

459

2.66

29.21

1.6

1.9

15.7

15.9

0.05

201

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1137

5460

1.46

29.13

2.6

1.4

g/l

3.8

0.84

819

3853

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4708

27605

1.22

29.02

1.7

mg/l

1.5

1.2

3.95

3626

21258

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

881

4022

1.53

28.88

2.6

1.5

g/l

0.0

0.52

798

3640

(3052851) Hemolysis interference index of Serum or Plasma

839

3795

1.54

28.68

3.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1075

5123

1.47

28.64

2.6

1.4

g/l

10.1

10.3

0.43

885

4239

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

816

3682

1.55

28.20

2.6

1.5

g/l

0.0

0.00

743

3362

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

464

1810

1.78

28.08

1.7

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

825

3745

1.54

27.76

2.6

1.5

g/l

0.0

0.50

745

3374

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

582

2430

1.67

27.67

1.7

1.5

—

(40768797) Stomach Pathology biopsy report

3262

18485

1.25

27.48

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7306

44787

1.18

27.43

2.2

u/l

210.0

219.4

0.28

6772

41608

(3011397) Hemoglobin [Presence] in Urine by Test strip

5364

32018

1.20

27.20

4.1

3.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

599

2536

1.65

27.01

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

4931

29232

1.21

26.84

1.3

—

(21494755) Public health laboratory ask at order entry panel

648

6888

0.64

26.52

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

158

412

2.66

26.29

29.1

34.7

ug/l

7.0

7.2

0.27

132

374

(40761536) Microorganisms panel - Urine sediment

1912

10191

1.32

26.04

4.8

4.1

—

(40765096) Chromosome analysis panel by Banding

167

3.73

25.95

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

240

765

2.18

25.87

1.5

1.4

u/l

14.4

13.4

0.92

227

733

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2302

12615

1.29

25.48

4.0

3.7

kpa

5.8

5.9

2.66

2240

12239

(40760892) CBC W Ordered Manual Differential panel - Blood

4341

25533

1.21

25.45

4.9

4.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

763

3472

1.53

25.40

1.6

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2375

13077

1.28

25.31

2.9

3.0

ng/l

249.2

224.1

1.40

2171

11997

(3010503) CD19 cells [#/volume] in Blood

162

437

2.57

25.25

2.2

2.1

e9/l

0.2

0.16

152

419

(3002032) Base excess in Venous blood by calculation

2295

12587

1.29

25.22

4.0

3.7

mmol/l

1.7

2.0

3.30

1912

10315

(3005719) IgG [Mass/volume] in Serum or Plasma

1593

8309

1.35

25.13

3.4

2.3

g/l

10.4

10.8

1.92

1454

7526

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1026

4977

1.44

24.92

1.9

ug/l

2.5

2.1

0.45

872

4326

(3017143) Hepatitis C virus Ab [Presence] in Serum

1776

9442

1.32

24.58

1.6

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

710

3216

1.54

24.15

3.7

1.6

—

(3012544) pH of Venous blood

2371

13134

1.27

24.00

4.0

3.7

7.4

0.66

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

44.15

23.37

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

620

2747

1.57

23.26

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

620

2748

1.57

23.22

1.3

—

(40761535) Cells panel - Urine sediment

2177

11998

1.28

22.92

4.0

3.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

170

493

2.39

22.85

2.2

2.0

e6/l

504.3

502.7

0.01

137

424

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

164

469

2.42

22.72

2.3

2.0

e9/l

0.3

0.2

0.73

140

418

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1854

10044

1.30

22.30

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

221

726

2.11

22.18

1.7

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

19524

130211

1.20

22.11

5.0

4.9

mmol/l

4.5

4.6

31.80

17482

119491

(3019225) pH of Specimen

2467

13882

1.25

21.76

4.6

3.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

645

2930

1.53

21.69

2.4

g/l

3.6

0.25

617

2779

(40768441) Liver Pathology biopsy report

170

512

2.30

21.06

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

5823

35665

1.17

20.78

4.9

4.3

estimate

0.0

0.12

1931

10828

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

773

3679

1.46

20.77

1.3

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1267

6581

1.35

20.50

2.2

1.5

g/l

1.5

1.2

1.99

1123

5933

(3024354) Oxygen [Partial pressure] in Venous blood

1918

10546

1.28

20.50

3.2

3.1

kpa

4.7

4.5

2.41

1858

10198

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1132

5797

1.36

20.07

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

19334

129089

1.18

19.84

4.9

4.8

mmol/l

1.5

3.35

17201

117664

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1481

7907

1.31

19.81

2.5

—

(4281824)

204

680

2.08

19.78

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

11.51

19.61

1.1

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

134

374

2.48

19.61

4.2

3.0

—

(3037121) Protein [Mass/volume] in Urine

863

4247

1.42

19.40

3.2

2.6

g/l

0.3

0.11

354

1443

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

976

4913

1.39

19.24

1.8

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1049

5344

1.37

19.22

2.0

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1262

6617

1.33

19.17

8.3

9.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

18715

124713

1.17

19.11

4.4

4.3

mmol/l

1.2

1.3

22.62

16458

112650

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

362

1473

1.71

19.08

1.7

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

18.85

1.0

0.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1868

10345

1.27

18.78

2.3

1.8

nmol/l

374.4

367.5

0.68

1696

9336

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.22

18.76

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

129

364

2.45

18.49

2.6

2.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

193

3.04

18.24

1.6

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

382

1601

1.66

18.07

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

297

1171

1.76

17.54

1.7

1.5

—

(21494434) Karyotype in Bone marrow

251

943

1.84

17.36

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

200

697

1.99

17.27

1.3

—

(3016228) CD19 cells/100 cells in Blood

254

2.70

17.17

1.6

2.0

9.4

8.7

0.18

244

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

302

1208

1.73

16.98

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

588

2770

1.48

16.71

2.6

2.5

15.8

16.4

2.46

332

1447

(46235355) HIV 1 and 2 tests - Meaningful Use set

2047

11626

1.23

16.41

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

289

1154

1.74

16.37

4.7

2.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

709

3488

1.41

16.02

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1875

10576

1.24

16.01

2.9

2.4

ml/min/173m2

57.5

62.1

6.38

845

4163

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2365

13678

1.21

15.87

2.4

ug/l

6.2

7.6

3.42

1989

11822

(3051651) Icteric interference index of Serum or Plasma

178

614

2.01

15.86

3.6

4.1

—

(3047189) Immunofixation for 24 hour Urine

142

449

2.19

15.83

1.6

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

713

3521

1.41

15.78

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

713

3531

1.40

15.53

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

244

2.64

15.51

1.6

2.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

284

1147

1.72

15.48

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

444

2008

1.54

15.37

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

321

1352

1.65

14.99

3.4

3.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3160

18867

1.18

14.86

8.7

7.1

—

(3000060) B lymphocytes [#/volume] in Blood

139

3.18

14.84

1.7

2.0

e6/l

1656.2

134.0

0.75

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

122

374

2.26

14.68

1.5

1.4

65.1

64.1

0.11

101

299

(3006245) CD3-CD19+ cells/100 cells in Blood

220

2.67

14.57

1.7

2.0

10.8

9.0

0.48

202

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1473

8172

1.26

14.54

3.7

3.4

mmol/l

1.6

1.9

1.65

1091

6051

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

240

942

1.76

14.49

1.5

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

240

942

1.76

14.49

1.5

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

240

942

1.76

14.49

1.5

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1538

8589

1.25

14.34

3.8

3.5

kpa

5.1

5.2

3.45

1418

7877

(3009343) pH of Capillary blood

1517

8471

1.25

14.16

3.8

3.5

7.4

1.11

242

1036

(21494890) Protein electrophoresis panel - 24 hour Urine

304

1282

1.64

14.16

1.9

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

251

1012

1.72

13.83

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

545

2630

1.44

13.76

1.6

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

249

1010

1.71

13.44

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10132

65662

1.11

13.41

2.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

152

2.95

13.40

1.5

1.4

10.7

9.3

0.18

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

222

2.58

13.40

1.7

1.8

29.1

26.2

0.82

207

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

575

2824

1.41

13.20

2.2

2.4

208.9

192.6

4.03

539

2652

(3042631) Mycobacterium sp identified in Specimen

371

1670

1.54

13.19

2.9

—

(3036489) Thrombin time

796

4127

1.34

13.11

1.8

1.9

22.0

21.8

0.30

719

3613

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6091

38415

1.13

12.96

3.3

2.6

u/l

34.2

34.5

0.13

5672

35995

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7768

49686

1.12

12.93

4.8

4.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

383

1744

1.52

12.93

1.6

1.4

—

(3035880) pH of Pleural fluid

166

603

1.91

12.87

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1184

6506

1.27

12.68

2.7

2.8

0.6

0.7

0.44

1134

6217

(3000570) Elastase.pancreatic [Mass/mass] in Stool

735

3785

1.35

12.67

1.4

ug/g

266.6

282.7

1.46

456

2224

(3017354) Segmented neutrophils/100 leukocytes in Blood

252

1043

1.67

12.66

3.8

2.8

60.8

61.1

0.06

168

679

(1616796) Gas panel - Central venous blood

568

2805

1.41

12.65

3.9

3.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

149

526

1.96

12.57

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

149

526

1.96

12.57

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

260

1088

1.66

12.54

1.6

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.57

12.46

1.4

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

608

3055

1.38

12.25

2.0

2.1

89.2

90.4

0.66

573

2818

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1429

11960

0.81

12.14

1.6

1.7

1.5

0.77

1174

10147

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

352

1604

1.52

11.89

6.2

6.3

mg/l

12.3

12.0

0.36

324

1453

(3020891) Body temperature

1030

5612

1.28

11.84

4.6

4.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1196

6647

1.25

11.65

2.7

2.8

1.1

1.2

4.32

1190

6616

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11948

78431

1.10

11.60

3.1

3.0

u/l

53.0

48.5

4.69

10775

71462

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

258

1102

1.62

11.53

2.7

2.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

300

1330

1.56

11.48

3.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

101

319

2.19

11.44

1.5

1.4

3.8

2.5

0.72

264

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

17.75

10.86

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

158

599

1.82

10.83

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

157

595

1.83

10.78

1.6

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

370

1741

1.47

10.76

1.5

1.4

u/ml

20.1

15.1

0.40

(3028271) Lactate [Moles/volume] in Capillary blood

425

2057

1.43

10.67

1.9

1.8

mmol/l

1.6

1.7

2.34

413

2012

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

374

1770

1.46

10.57

1.5

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

336

1557

1.50

10.55

1.6

1.4

u/ml

110.7

118.9

0.76

345

(3010421) pH of Blood

641

3329

1.34

10.52

4.1

4.0

7.4

1.48

549

2784

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

389

1857

1.45

10.52

1.5

1.4

pmol/l

194.7

83.0

2.18

377

1815

(3024316) Viscosity of Plasma

6.27

10.33

1.3

1.4

mpas

1.9

1.4

1.07

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

257

2.26

10.30

1.4

1.3

ug/l

90.1

38.2

0.51

121

(3019060) Gas panel - Arterial blood

1590

9226

1.20

10.24

4.1

4.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

212

890

1.65

10.20

1.6

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

332

1548

1.49

10.13

1.5

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

+∞

9.87

1.1

0.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

138

517

1.85

9.87

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

138

517

1.85

9.87

1.6

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

138

517

1.85

9.87

1.6

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

176

711

1.71

9.79

1.6

1.3

—

(3048879) Bone marrow aspiration report

313

2.10

9.76

1.4

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

138

519

1.84

9.76

1.6

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

560

2888

1.35

9.67

4.2

4.1

kpa

8.5

8.4

0.62

554

2807

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

225

2.30

9.65

2.2

1.4

u/l

21.5

36.3

0.84

200

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

438

2172

1.40

9.64

1.3

1.2

u/l

50.9

25.3

2.06

371

1866

(3012501) Base excess in Blood by calculation

555

2862

1.35

9.59

4.2

4.1

mmol/l

2.5

2.6

0.48

383

1957

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

467

2344

1.38

9.57

3.9

3.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

555

2864

1.34

9.55

4.2

4.1

kpa

4.9

5.0

2.62

549

2784

(44806118)

259

1161

1.54

9.53

1.6

1.5

—

(44790049)

259

1162

1.54

9.50

1.6

1.5

—

(44790048)

259

1162

1.54

9.50

1.6

1.5

—

(44790047)

259

1162

1.54

9.50

1.6

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

627

3299

1.32

9.45

3.5

3.1

nmol/l

0.8

1.21

484

2566

(3007164) IgA [Mass/volume] in Serum or Plasma

3504

21731

1.13

9.44

1.6

1.3

g/l

2.5

2.6

1.12

1907

12189

(3041096) Erythrocytes [Presence] in Urine by Automated

5179

32859

1.11

9.39

4.1

3.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

898

4958

1.26

9.32

2.3

ug/l

420.4

625.3

1.78

840

4654

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

281

1290

1.51

9.29

1.2

u/l

60.9

57.7

0.37

191

829

(3024891) Influenza virus A+B Ag [Presence] in Specimen

524

2694

1.35

9.26

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

106

372

1.97

9.23

1.6

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

602

3161

1.32

9.22

2.3

2.1

g/l

126.9

130.4

2.62

430

2290

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

108

382

1.95

9.20

1.7

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

108

383

1.95

9.14

1.7

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

109

389

1.94

9.06

1.7

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

391

1928

1.41

8.93

1.3

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

261

2.14

8.85

2.8

2.1

—

(3024928) Oxygen saturation in Venous blood

543

2828

1.33

8.82

2.5

3.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

239

1073

1.54

8.78

1.8

1.7

g/24h

0.4

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

548

2865

1.33

8.68

3.0

2.9

kpa

8.0

7.9

1.12

520

2661

(3021901) Oxygen saturation in Capillary blood

484

2495

1.35

8.44

2.9

2.8

—

(3014891) Appearance of Pleural fluid

176

2.35

8.18

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

334

1639

1.41

7.91

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

297

2.00

7.90

1.4

21.2

21.8

0.06

265

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

934

5283

1.23

7.85

4.0

3.8

mmol/l

24.8

24.9

0.85

844

4818

(3004119) Hemoglobin [Mass/volume] in Venous blood

1469

8674

1.18

7.80

3.4

3.3

g/l

126.1

130.0

9.41

1429

8460

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

315

1534

1.42

7.79

1.1

g/l

1.5

0.11

284

1364

(3003181) Sodium [Moles/volume] in Urine

481

2512

1.33

7.73

1.3

mmol/l

59.5

63.5

1.52

393

2005

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

178

772

1.59

7.66

1.6

1.5

u/l

9.8

6.0

0.99

342

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

316

1547

1.41

7.60

1.3

1.2

u/ml

301.8

293.9

0.17

186

998

(3043409) Potassium [Moles/volume] in Arterial blood

769

4278

1.25

7.55

4.0

4.4

mmol/l

3.9

0.39

738

4025

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4915

31425

1.10

7.42

1.8

1.7

pmol/l

26078369.9

32061233.1

0.33

3850

25461

(3023383) Lactate [Moles/volume] in Pleural fluid

324

1.92

7.38

1.3

1.4

mmol/l

3.8

3.3

0.70

291

(3009508) Creatinine [Moles/volume] in Urine

7140

46432

1.09

7.35

3.3

3.2

mmol/l

6.9

7.3

9.54

5784

38682

(3000012) Reticulocyte production index

170

737

1.60

7.35

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

869

4915

1.23

7.34

3.8

4.1

mmol/l

1.4

0.36

859

4819

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.39

7.32

1.8

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

423

2190

1.34

7.24

1.3

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

638

3494

1.27

7.19

3.1

mmol/l

24.6

24.9

1.50

577

3081

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1463

8712

1.17

7.02

6.3

6.9

mmol/l

24.4

24.6

1.23

1366

8108

(3048689) Calprotectin [Mass/mass] in Stool

2266

13921

1.14

7.02

2.3

2.1

ug/g

137.2

139.7

0.12

1752

10721

(40758292) HTLV I+II Ab panel - Serum

3.06

6.94

1.4

1.3

—

(3022313) Gas panel - Capillary blood

1062

6162

1.20

6.92

3.9

3.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

189

1935

0.67

6.73

1.0

1.1

iu/ml

75.5

6668.4

0.56

365

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

230

2.04

6.67

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

867

4957

1.21

6.62

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

182

824

1.53

6.57

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

291

2745

0.73

6.50

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

202

941

1.48

6.39

1.2

—

(3012516) Albumin [Mass/volume] in Urine

7005

45726

1.08

6.37

3.4

3.2

mg/l

381.4

319.3

0.54

4317

28431

(3036603) Volume of Urine

173

782

1.53

6.31

1.6

1.4

1747.2

1955.1

0.81

196

(3001019) Free T4 and TSH panel - Serum or Plasma

456

4018

0.78

6.26

1.6

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

312

1579

1.37

6.26

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

312

1580

1.37

6.23

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

178

812

1.52

6.23

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

315

1599

1.36

6.20

1.4

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

128

2.37

6.20

1.5

1.3

13.9

26.3

2.09

(3005988) Vibrio sp identified in Specimen by Organism specific culture

312

1585

1.36

6.12

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

116

480

1.67

6.10

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

187

2.10

6.09

12.1

11.6

mmol/l

5.7

5.1

0.52

187

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

104

2.52

6.08

1.7

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

323

1653

1.35

6.05

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

314

1600

1.36

6.05

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

142

622

1.58

5.97

1.9

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

144

2.25

5.92

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

354

1847

1.33

5.85

2.0

2.1

mg/l

29.4

26.4

0.37

102

480

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

165

752

1.52

5.83

2.3

2.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

160

725

1.53

5.81

1.3

1.2

u/l

27.7

22.9

0.63

137

608

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5750

37373

1.08

5.73

1.7

mmol/l

1.3

4.72

4682

30774

(3025941) Bacteria identified in Stool by Culture

1092

6464

1.17

5.71

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

160

729

1.52

5.68

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

166

2.12

5.59

3.5

2.5

mg/l

21.8

50.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

317

1.79

5.52

1.3

2.0

u/ml

4158.3

38283.5

0.71

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

2.19

5.46

6.5

4.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

110

2.38

5.45

2.2

1.2

ng/l

145.8

96.8

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.84

5.33

1.1

1.0

—

(3008295) Osmolality of Serum or Plasma

241

1203

1.39

5.33

1.3

1.4

mosm/kgh2o

277.2

276.1

0.28

178

905

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2894

18310

1.10

5.32

5.0

33.7

32.9

3.70

1833

12202

(3020191) Ethanol [Moles/volume] in Serum or Plasma

962

0.59

5.28

1.1

1.4

promille

0.9

1.3

2.18

726

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

156

719

1.50

5.28

2.0

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

139

1434

0.67

5.26

1.4

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

134

2.22

5.25

2.2

2.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

7342

48278

1.07

5.25

4.1

4.0

mg/mmol

9.7

8.4

1.38

4411

30086

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

161

750

1.48

5.18

1.2

u/l

101.6

87.0

0.83

140

646

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

664

3795

1.21

5.18

1.6

g/l

1.2

0.18

636

3586

(3028300) Cannabinoids [Presence] in Urine

141

1443

0.67

5.13

1.4

1.6

—

(3027008) Opiates [Presence] in Urine

141

1440

0.67

5.08

1.4

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

102

1114

0.63

5.07

1.5

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

150

2.12

5.05

1.5

—

(3017704) Immunofixation for Urine

159

743

1.48

5.05

1.4

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.67

5.01

1.8

1.3

nmol/l

316.7

574.1

1.31

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1163

7001

1.15

4.93

3.4

2.5

e6/l

0.3

0.57

1140

6815

(3028707) Methadone [Presence] in Urine by Screen method

715

0.55

4.90

1.7

1.9

—

(3016879) Cocaine [Presence] in Urine

130

1337

0.67

4.88

1.4

1.7

—

(3023419) Bacteria identified in Sputum by Culture

327

1742

1.30

4.74

2.7

2.5

—

(3046861) Legionella sp Ag [Presence] in Urine

2.74

4.73

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

297

1.74

4.72

1.7

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

282

1.76

4.70

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

494

2773

1.23

4.64

1.4

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

138

640

1.49

4.60

1.2

1.1

iu/ml

3.2

4.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

580

4803

0.83

4.59

1.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

249

1.80

4.58

1.4

20.6

25.9

0.91

204

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.51

4.52

2.1

4.4

mg/l

1.0

1.5

1.20

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

4.49

1.0

0.0

—

(3027944) Amphetamines [Presence] in Urine

141

1403

0.69

4.48

1.4

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

261

1.77

4.48

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

130

600

1.50

4.45

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

130

600

1.50

4.45

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

369

3188

0.80

4.42

1.5

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

114

513

1.54

4.39

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1401

8612

1.13

4.37

3.0

2.9

e9/l

4.2

4.0

1.06

986

6215

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1086

6571

1.15

4.32

4.4

3.9

48.7

47.5

0.94

1076

6494

(3004451) EKG impression Narrative

144

686

1.45

4.23

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

319

2785

0.79

4.20

1.9

1.5

nmol/l

0.8

0.18

266

2277

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1008

6081

1.15

4.20

1.6

1.5

u/ml

12.7

16.9

0.49

144

(3003338) MCHC [Mass/volume]

15615

105530

1.06

4.19

24.6

17.9

g/l

331.1

331.9

28.29

15486

104632

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

143

684

1.44

4.12

3.8

4.0

—

(40768446) Kidney Pathology biopsy report

434

1.56

4.08

1.7

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1148

7005

1.14

4.05

3.0

pmol/l

4.4

0.47

978

6116

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.55

4.02

2.7

1.4

—

(3014271) Vancomycin [Susceptibility]

168

832

1.40

4.01

3.1

—

(3020393) Adenovirus Ag [Presence] in Stool

100

2.21

3.96

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

5628

40717

0.94

3.96

3.3

3.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

610

4957

0.84

3.95

1.5

—

(3028433) Virus identified in Specimen by Culture

378

1.59

3.94

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.96

3.92

1.1

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

525

4316

0.84

3.90

1.6

1.5

—

(3033799) Differential panel - Peritoneal fluid

303

1.64

3.72

1.7

2.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

291

1582

1.27

3.71

5.0

12.7

mmol/l

7.0

7.6

1.98

237

1290

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

987

7701

0.88

3.70

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

241

1.72

3.68

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method

935

0.66

3.67

1.9

2.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.65

3.63

4.8

4.7

—

(3008898) HLA-B27 [Presence]

385

3232

0.82

3.60

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

318

1.61

3.54

1.6

umol/l

2.2

2.0

0.76

294

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1380

8591

1.11

3.53

2.5

2.4

au/ml

30.7

0.00

344

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

129

1.98

3.52

2.8

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.37

3.49

7.0

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

212

1.73

3.33

1.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

108

2.04

3.33

1.2

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

653

3894

1.16

3.27

1.5

iu/ml

10.3

16.6

1.13

(4198724)

245

0.39

3.21

1.1

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

108

1053

0.71

3.19

3.6

3.3

13.2

13.3

0.49

108

1037

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

127

627

1.40

3.18

1.2

1.1

u/l

82.7

83.3

0.03

103

483

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

127

628

1.40

3.15

1.2

1.1

u/l

28.2

21.6

0.67

100

464

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.31

3.12

8.4

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

462

2691

1.19

3.11

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1141

7083

1.12

3.11

3.9

3.3

mmol/l

25.1

25.4

2.35

1110

6869

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

787

6150

0.88

3.09

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

876

5356

1.13

3.08

1.9

u/l

38.9

39.0

0.05

746

4631

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

182

1.74

3.04

1.2

1.3

ng/l

127.4

122.1

0.03

128

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

148

757

1.35

3.01

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

132

667

1.37

2.91

1.3

nmol/l

0.3

0.2

0.14

102

489

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

185

1.72

2.89

2.0

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2926

21412

0.93

2.88

1.3

u/ml

15.2

14.9

0.06

942

7794

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

130

1208

0.74

2.88

1.1

1.0

ng/l

37.8

45.5

1.33

806

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1241

7777

1.11

2.86

1.3

au/ml

59.2

51.6

0.42

323

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

641

1.37

2.83

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

424

0.57

2.83

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

130

1204

0.74

2.82

1.1

1.0

ng/l

706.3

714.8

0.07

786

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

338

1.51

2.81

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

116

1.90

2.79

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

322

1.52

2.78

1.8

2.2

e6/l

11751.4

14852.5

0.16

165

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.20

2.78

2.0

2.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

102

1.96

2.76

1.2

1.1

mg/l

7.1

9.2

0.69

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

103

505

1.41

2.74

2.8

2.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

130

1197

0.75

2.73

1.1

1.0

ng/l

299.1

336.5

0.94

814

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

562

3367

1.15

2.72

2.0

1.9

mg/l

11.7

11.3

0.48

518

3098

(3052592) Norovirus Ag [Presence] in Stool

253

1.58

2.70

1.3

—

(3021788) Differential panel - Synovial fluid

483

2863

1.17

2.69

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

108

1.92

2.68

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

118

1.87

2.67

1.3

1.1

u/l

20.7

18.1

0.22

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

771

4728

1.13

2.64

1.6

titre

194.7

266.8

0.37

239

(3016038) Potassium [Moles/volume] in Urine

179

961

1.29

2.64

1.1

mmol/l

36.1

33.8

0.63

149

794

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

109

1.90

2.62

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

109

1.90

2.62

1.2

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

4.25

2.54

6.6

3.6

mg/l

3.8

4.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

191

1650

0.80

2.47

1.8

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

383

3095

0.85

2.47

1.1

u/ml

9.0

9.9

0.07

266

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

401

1.43

2.43

7.6

5.8

73.1

70.7

0.41

336

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

126

653

1.33

2.43

2.4

2.3

—

(40757373) Influenza virus identified in Isolate

255

1.54

2.42

1.9

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

154

1.70

2.38

2.2

2.1

—

(3012565) Volume of 24 hour Urine

118

608

1.34

2.37

1.9

1679.5

1920.9

1.68

103

523

(40757494) Bilirubin.total [Moles/volume] in Blood

152

813

1.29

2.35

2.3

2.0

umol/l

15.7

16.4

0.08

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

102

515

1.37

2.34

3.7

2.0

u/l

215.0

205.2

0.77

102

509

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.07

2.33

1.1

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

135

713

1.31

2.30

2.1

2.2

ug/min

91.5

132.1

0.41

167

(3002331) Protein [Mass/volume] in Peritoneal fluid

242

1.54

2.29

1.5

1.6

g/l

29.5

49.4

0.37

182

(3016650) Hepatitis A virus Ab [Presence] in Serum

276

1584

1.20

2.29

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

624

1.33

2.28

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.35

2.23

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

158

1.66

2.19

2.2

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

285

1650

1.19

2.18

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

148

1.68

2.17

4.3

1.4

u/l

41.2

64.1

0.65

(4010399)

1628

10473

1.08

2.15

1.5

—

(4212803)

113

1.77

2.10

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

139

1.69

2.10

1.2

1.3

u/l

145.2

272.9

0.20

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.83

2.09

1.5

1.6

—

(3044927) Protein electrophoresis panel - Urine

278

1613

1.19

2.09

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

106

550

1.33

2.08

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

368

1.41

2.07

1.9

2.4

e6/l

2186.4

2330.1

0.02

259

(3025315) Body weight

114

1.76

2.05

4.8

5.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.92

2.04

3.3

2.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.51

2.03

1.4

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

272

0.56

2.01

6.6

7.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

436

1.36

1.98

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

163

1.61

1.98

1.2

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.20

1.95

1.0

1.1

37.1

36.1

0.35

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.20

1.95

1.0

1.1

21.8

22.0

0.04

(3042733) HLA Ab [Presence] in Serum

350

1.40

1.93

5.6

5.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3146

22690

0.95

1.93

1.3

iu/ml

34.6

40.8

1.45

959

7116

(3045424) Erythrocytes [Presence] in Urine

383

2298

1.15

1.93

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.45

1.92

1.0

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.65

1.88

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

312

1.42

1.86

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

171

1442

0.82

1.86

1.1

1.2

mmol/l

7.9

7.6

0.51

122

1011

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.08

1.84

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3913

25968

1.05

1.84

1.3

1.2

u/ml

1.6

1.7

0.05

915

6733

(3008536) Aspergillus sp Ab [Presence] in Serum

194

1.53

1.83

1.4

1.5

—

(3027874) Urate [Moles/volume] in Urine

2.20

1.82

1.0

1.1

mmol/l

1.9

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

140

1.63

1.81

1.2

ug/l

62.5

122.1

3.08

(3024471) HLA-A [Type]

314

1.41

1.81

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.22

1.80

1.0

1.7

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.90

1.80

2.3

2.1

—

(3025577) Chromium [Mass/volume] in Blood

196

1120

1.21

1.79

2.0

2.1

ug/l

2.4

0.02

163

931

(3023183) Ammonium ion [Moles/volume] in Plasma

428

2606

1.14

1.77

2.7

2.5

umol/l

33.0

33.3

0.09

349

2203

(3014133) Dog dander IgE Ab [Units/volume] in Serum

107

942

0.78

1.74

1.1

1.0

u/ml

0.8

2.9

3.85

361

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

223

1294

1.19

1.73

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

148

1255

0.81

1.73

1.1

u/ml

0.8

0.9

0.13

473

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

342

2055

1.15

1.72

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

100

1.73

1.71

1.1

iu/ml

11.3

14.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

316

1890

1.16

1.70

2.7

2.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

159

1.56

1.70

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.01

1.70

1.0

1.1

—

(3013862) HLA-DP [Type]

3.02

1.69

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

4458

29733

1.04

1.67

5.0

4.3

kg/l

1.0

0.57

622

4569

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

257

2062

0.86

1.64

1.8

1.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

220

0.56

1.63

1.3

1.6

—

(3024932) HLA-DR beta [Type]

309

1.38

1.63

1.1

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

524

1.29

1.63

2.2

4.9

mg/l

2328.0

542.3

0.37

357

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.97

1.63

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

145

1.57

1.61

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

287

1.39

1.60

1.2

1.1

85.4

90.2

0.38

146

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

447

1.31

1.60

2.3

1.7

165.2

157.3

0.34

415

(3038071) Oxygen [Partial pressure] in Mixed venous blood

337

0.65

1.59

7.4

7.6

—

(3026470) Cobalt [Mass/volume] in Blood

199

1155

1.19

1.58

1.9

2.0

ug/l

3.4

3.9

0.59

179

1023

(3044941) Cell count panel - Synovial fluid

399

2442

1.13

1.56

1.5

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

230

1852

0.86

1.55

4.1

4.7

umol/l

328.6

358.3

2.27

191

1561

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

147

1.55

1.53

1.9

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

143

0.48

1.51

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

204

1.45

1.50

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

277

1660

1.15

1.49

1.3

1.2

—

(40760409) HLA-A [Type] by High resolution

2.96

1.48

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.96

1.48

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

2.96

1.48

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

2.96

1.48

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

2.96

1.48

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

391

2400

1.13

1.48

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

222

1.43

1.47

1.5

1.6

ug/l

107.2

120.7

0.35

186

(3023430) Cat dander IgE Ab [Units/volume] in Serum

102

882

0.80

1.47

1.1

1.0

u/ml

2.8

2.7

0.01

329

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.30

1.46

1.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

202

1185

1.18

1.44

1.5

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

140

794

1.22

1.44

11.3

10.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.97

1.44

1.4

1.3

—

(3023410) Appearance of Cerebral spinal fluid

191

1116

1.18

1.43

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

180

1465

0.85

1.42

1.1

u/ml

0.8

1.1

0.39

564

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

173

1.48

1.40

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

243

1930

0.87

1.40

1.9

1.8

mu/l

433.5

312.1

0.35

220

1758

(3009214) Lutropin [Units/volume] in Serum or Plasma

284

1716

1.14

1.39

1.3

u/l

13.1

10.6

1.88

226

1359

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

257

1542

1.15

1.39

1.1

au/ml

12.9

12.3

0.04

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

298

1808

1.14

1.37

1.3

1.2

nmol/l

3.6

2.1

0.21

279

1733

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.23

1.37

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.23

1.37

1.5

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

154

888

1.20

1.36

1.2

1.3

mmol/l

2.1

2.2

0.41

137

824

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

274

0.65

1.34

1.5

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

152

878

1.20

1.32

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

208

1234

1.16

1.32

1.4

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.02

1.32

1.8

1.4

2.5

2.1

0.14

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

245

1.38

1.32

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.67

1.32

1.0

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.95

1.31

1.8

1.4

mg/l

1.7

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

298

1816

1.13

1.30

1.3

1.2

nmol/l

0.2

0.3

0.67

138

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

536

1.25

1.30

2.0

1.9

100.9

95.8

0.72

499

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

196

0.60

1.29

1.6

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

108

606

1.23

1.27

1.1

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

166

1.45

1.26

1.3

mmol/l

0.8

1.5

0.69

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.30

1.26

1.0

1.2

3.0

2.8

—

(4062490)

205

1223

1.16

1.23

1.7

1.4

—

(3044007) Cell count panel - Peritoneal fluid

297

1.32

1.21

2.0

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

309

1.32

1.21

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

131

1077

0.84

1.20

1.1

1.0

u/ml

0.3

1.4

2.75

232

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

168

1.44

1.20

1.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

1.18

0.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

219

1318

1.15

1.18

2.5

2.0

titre

4.2

3.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

317

2442

0.89

1.18

1.3

iu/l

34.6

36.7

0.51

277

2108

(3051101) Glucose [Moles/volume] in Cord blood

346

0.72

1.17

6.4

6.0

—

(3045414) Leukocytes [Presence] in Urine

955

6185

1.07

1.17

1.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

155

909

1.18

1.17

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

433

0.75

1.17

1.7

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

433

0.75

1.17

1.7

2.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

287

1.32

1.16

1.4

1.6

g/l

15.5

12.7

1.91

210

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

293

1.32

1.16

1.2

1.1

84.9

89.0

0.43

144

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.62

1.16

1.3

1.1

—

(4034850)

656

4877

0.93

1.15

12.7

10.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

358

2226

1.11

1.15

1.4

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

296

0.70

1.14

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

180

0.61

1.13

1.1

1.4

mmol/l

9.0

9.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

302

1862

1.12

1.13

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

103

584

1.22

1.13

1.2

1.5

umol/l

15.7

9.7

0.51

414

(3000492) Spirometry study

1682

11087

1.05

1.12

1.7

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

161

1291

0.86

1.12

1.1

u/ml

2.6

2.5

0.07

569

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

131

761

1.19

1.12

1.7

1.4

u/l

5.7

5.8

0.11

108

638

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

767

0.82

1.11

1.1

1.0

u/ml

0.1

0.3

0.55

182

(3006567) Chloride [Moles/time] in 24 hour Urine

2.30

1.11

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

230

1.35

1.10

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

103

1.54

1.10

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

389

0.74

1.10

9.2

7.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

529

0.78

1.09

9.3

6.5

mmol/l

24.9

25.3

0.41

476

(21491868) Cryoglobulin [Mass/volume] in Serum

425

1.25

1.08

1.1

1.2

g/l

0.6

0.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

154

910

1.17

1.08

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

787

0.82

1.08

1.2

1.4

nmol/l

1.0

1.3

2.13

601

(3028192) IgG subclass 2 [Mass/volume] in Serum

203

1225

1.14

1.08

1.7

1.4

g/l

2.6

3.0

3.37

146

856

(3024139) IgG subclass 3 [Mass/volume] in Serum

203

1225

1.14

1.08

1.7

1.4

g/l

0.4

1.20

145

861

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.55

1.08

1.0

1.1

u/l

9.0

11.5

0.27

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

115

663

1.20

1.07

1.5

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

895

5805

1.07

4.5

4.7

1.5

1.6

2.26

839

5468

(3049242) von Willebrand panel - Platelet poor plasma

2.07

1.07

1.3

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

203

1226

1.14

1.07

1.7

1.4

g/l

6.1

6.9

2.66

146

856

(3007916) DNA double strand Ab [Titer] in Serum

185

0.63

1.06

1.2

1.3

—

184.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

451

2851

1.09

1.06

1.2

titre

109.1

132.3

0.19

(3001686) Cold agglutinin [Titer] in Serum or Plasma

244

1.33

1.05

1.4

titre

334.9

200.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

508

1.22

1.05

1.3

umol/l

22.6

22.1

0.06

473

(3032057) Clostridioides difficile [Presence] in Stool

323

1.28

1.04

1.7

1.6

—

(3039000) Anion gap in Blood

458

2900

1.09

1.04

5.6

6.4

mmol/l

11.2

11.3

0.38

408

2617

(3018572) Chloride [Moles/volume] in Blood

458

2900

1.09

1.04

5.6

6.4

mmol/l

105.0

104.8

0.36

408

2617

(3016750) Collection duration of Urine

147

869

1.17

1.04

2.6

2.1

min

496.8

501.3

0.24

109

650

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

167

0.62

1.03

1.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.70

1.03

2.0

1.1

pmol/l

41.6

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

879

5712

1.06

1.01

4.6

4.7

0.9

1.12

824

5372

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

507

0.79

1.01

1.1

u/ml

2.8

8.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

157

0.61

1.00

1.1

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

559

0.80

0.99

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

1440

9498

1.05

0.97

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.69

0.97

1.6

1.7

u/l

0.7

0.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

182

1.36

0.97

1.2

1.3

nmol/l

252010.5

320812.8

0.09

149

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2274

15151

1.04

0.96

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

441

2801

1.09

0.96

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

328

1.26

0.95

1.1

1.2

pmol/l

308.4

292.5

0.09

224

(3002619) Bacteria identified in Specimen by Culture

261

1.30

0.94

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

131

1.42

0.92

1.2

1.4

73.1

66.3

0.59

107

(3000475) Leukocytes [#/volume] in Synovial fluid

603

3887

1.07

0.91

1.7

1.6

e6/l

14107.8

13967.8

0.03

413

2824

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

209

1.32

0.89

1.4

1.1

ug/l

3.9

2.5

0.61

134

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

431

1.22

0.88

1.4

pmol/l

15.6

16.1

0.36

366

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

462

2957

1.08

0.86

1.5

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

182

1112

1.13

0.86

2.0

1.7

titre

1146.7

2669.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

122

725

1.16

0.85

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2393

16002

1.03

0.85

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

612

3959

1.07

0.85

5.0

4.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

578

3733

1.07

0.84

1.6

g/l

0.2

0.54

548

3528

(3034770) Mitochondria Ab [Titer] in Serum

508

3266

1.07

0.84

1.2

titre

788.3

1099.4

0.69

117

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.97

0.84

1.0

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

131

784

1.15

0.84

1.3

1.4

umol/l

14.3

13.4

0.57

125

735

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.69

0.84

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.69

0.84

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1379

9130

1.04

0.83

1.2

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

164

1.35

0.82

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

292

0.76

0.81

1.1

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.81

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

305

1.24

0.80

1.7

1.8

—

(4024509)

237

1478

1.11

0.80

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

752

4911

1.06

0.79

1.1

u/ml

4.4

5.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

232

1.28

0.79

1.2

mmol/l

1.3

1.5

0.65

119

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

155

0.67

0.78

1.8

umol/l

18.7

18.3

0.06

155

(3051387) C reactive protein [Mass/volume] in Capillary blood

420

3113

0.93

0.77

3.9

3.5

mg/l

31.7

26.0

1.97

243

2017

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

190

1174

1.12

0.77

2.0

2.1

u/field

2.4

0.05

420

(3022475) Manganese [Moles/volume] in Blood

1.69

0.77

1.4

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

121

0.63

0.76

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.16

0.76

1.2

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.16

0.76

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

241

1827

0.91

0.76

1.5

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.51

0.75

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.72

0.75

1.6

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

621

0.84

0.75

1.0

1.1

u/ml

1.6

5.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

460

3393

0.93

0.75

1.2

1.3

u/ml

7.7

6.3

0.16

581

(3045716) Anion gap in Serum or Plasma

695

0.85

0.74

3.4

2.3

mmol/l

8.9

9.0

0.01

509

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

613

0.84

0.74

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

348

0.79

0.73

1.8

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

253

1909

0.91

0.73

1.2

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

186

1.30

0.73

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

455

3353

0.93

0.72

1.2

1.3

u/ml

6.1

6.0

0.01

375

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

1.35

0.72

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

160

0.69

0.72

1.8

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.79

0.72

1.6

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

208

1298

1.11

0.72

1.5

iu/ml

29.1

28.3

0.04

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

707

4627

1.06

0.71

1.7

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

199

1.28

0.71

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

392

0.81

0.70

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

589

3837

1.06

0.70

1.7

—

(3024263) Appearance of Synovial fluid

132

804

1.13

0.70

1.7

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.44

0.70

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

544

3978

0.94

0.69

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

247

1860

0.92

0.69

1.2

1.3

miu/ml

179.1

204.9

0.52

750

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

200

1.28

0.69

1.3

1.2

101.0

82.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

111

669

1.15

0.69

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

170

1.30

0.68

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.55

0.68

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

118

923

0.88

0.67

1.2

mmol/l

11.5

11.9

0.27

272

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

201

1.27

0.67

1.3

1.2

84.7

73.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

510

1.16

0.67

1.2

1.3

g/l

39.9

39.7

0.02

271

(3006442) Creatine [Moles/volume] in Serum or Plasma

109

856

0.88

0.66

1.5

1.7

umol/l

71.1

70.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.41

0.66

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

760

0.87

0.66

1.2

1.4

pmol/l

88.0

111.8

0.23

225

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

110

666

1.14

0.65

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

490

3186

1.06

0.64

2.2

2.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

226

0.76

0.63

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

143

1100

0.90

0.63

1.1

1.2

u/ml

29.2

6.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

468

1.16

0.63

2.6

3.0

mu/l

32.1

24.0

0.62

439

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

118

720

1.13

0.63

1.9

2.0

u/field

1.6

2.3

0.86

478

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

469

3048

1.06

0.63

1.3

mg/l

592.6

541.1

0.92

439

2881

(40765089) Chromosome analysis panel - Blood by G-banded

1.49

0.63

1.0

—

(3025130) Human papilloma virus identified in Specimen

177

1106

1.10

0.63

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1895

13442

0.97

0.62

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.62

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

291

1.21

0.62

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

114

887

0.89

0.61

1.3

u/ml

2.1

1.2

0.39

468

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

218

1639

0.92

0.61

1.1

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

114

0.67

0.61

1.5

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

502

3661

0.94

0.61

1.2

1.3

u/ml

45.6

41.6

0.08

223

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

526

0.85

0.61

1.7

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

498

3247

1.06

0.61

1.2

titre

185.7

143.9

0.23

267

(3006653) Thiamine [Moles/volume] in Blood

103

625

1.14

0.60

1.1

1.2

nmol/l

135.8

137.4

0.11

103

625

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

331

0.81

0.60

1.7

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

331

0.81

0.60

1.7

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

330

0.81

0.59

1.7

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

330

0.81

0.59

1.7

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

349

2570

0.94

0.59

1.2

u/ml

36.6

48.8

0.65

275

(3024980) IgG subclass 4 [Mass/volume] in Serum

301

1933

1.07

0.59

1.8

1.6

g/l

0.7

0.8

2.20

231

1454

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

509

3704

0.95

0.58

1.6

1.7

mg/l

2.9

3.7

0.98

362

2639

(3028679) Herpes simplex virus Ab [Presence] in Serum

459

1.16

0.58

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

105

640

1.13

0.58

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

313

1.19

0.57

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

171

1293

0.91

0.56

1.1

u/ml

3.2

4.2

0.44

480

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

153

1163

0.91

0.56

1.1

1.2

u/ml

65.6

84.9

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.57

0.56

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.51

0.55

1.4

1.0

nmol/l

202.0

297.3

—

(3009871) Measles virus Ab [Titer] in Serum

334

0.83

0.54

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

154

1167

0.91

0.54

1.1

1.2

u/ml

41.4

44.9

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.48

0.54

6.2

5.7

umol/l

443.2

406.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

363

0.84

0.53

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

140

1.28

0.53

1.6

1.7

umol/l

57.2

46.2

0.78

140

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

164

1237

0.91

0.53

1.3

nmol/l

1.4

0.29

147

1123

(3011985) Renin [Units/volume] in Plasma

275

1770

1.07

0.52

1.4

1.3

mu/l

30.1

56.8

6.34

236

1575

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

107

825

0.89

0.52

1.4

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

438

1.15

0.52

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.53

0.52

6.2

7.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.53

0.52

1.8

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

291

1.19

0.52

2.6

1.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

165

1042

1.09

0.51

1.1

1.2

titre

380.0

118.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

311

1.18

0.51

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

273

1.19

0.50

1.1

1.2

mu/l

58.3

64.4

0.11

189

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

286

1.18

0.50

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

299

1.18

0.49

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

165

1044

1.09

0.49

1.1

1.2

titre

78.1

181.1

3.86

190

(44806420)

507

0.87

0.49

2.3

—

(3006462) Nitrate [Presence] in Urine

110

683

1.11

0.48

3.7

3.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

180

1145

1.08

0.48

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

439

0.86

0.47

1.0

u/ml

0.5

0.7

0.49

132

(3013762) Body weight Measured

1.46

0.47

1.0

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

257

1660

1.07

0.47

1.3

pmol/l

246.2

270.8

1.18

219

1254

(3017509) Phencyclidine [Presence] in Urine

0.59

0.46

1.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.43

0.46

3.3

3.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

187

1.22

0.46

1.3

mmol/l

7.0

6.7

0.11

(3001729) Color of Synovial fluid

130

0.74

0.46

1.2

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

144

1.25

0.44

2.7

2.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

531

0.88

0.44

2.1

1.9

ug/l

20.6

455.8

1.42

501

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

325

0.85

0.43

1.6

1.9

mg/l

10.1

9.2

0.38

262

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.64

0.43

1.0

1.1

u/field

0.4

0.6

—

(3004775) Volume in Urine collected for unspecified duration

195

1252

1.07

0.43

2.4

2.3

705.8

661.4

0.70

131

850

(3014148) Varicella zoster virus Ab [Titer] in Serum

165

1053

1.08

0.43

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

407

2675

1.05

0.43

1.2

1.3

mmol/l

3.7

3.9

1.69

368

2514

(3043238) Trisomy 21 risk [Likelihood] in Fetus

287

0.84

0.42

1.8

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.41

0.42

1.1

1.4

1.3

—

(3000330) Specific gravity of Urine by Test strip

1116

7483

1.03

0.42

4.2

3.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

378

2739

0.95

0.42

1.6

1.7

nmol/l

47.7

45.2

1.19

361

2624

(43055514) Macroprolactin [Presence] in Serum or Plasma

128

0.75

0.42

1.4

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.42

0.0

1.0

—

138.5

—

(3006270) Folate [Moles/volume] in Blood

193

1241

1.07

0.42

1.2

nmol/l

310.3

338.5

1.12

158

1004

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

102

1.28

0.41

1.1

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

214

1576

0.94

0.41

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

486

3212

1.04

0.41

3.9

3.3

mmol/l

7.4

7.7

1.96

475

3149

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

491

0.88

0.40

1.3

1.7

nmol/l

2.6

4.3

0.79

403

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

381

0.87

0.40

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

381

0.87

0.40

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

381

0.87

0.40

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

381

0.87

0.40

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.23

0.40

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

392

2831

0.95

0.39

1.2

u/ml

1.9

7.1

2.46

230

(3047352) Trisomy 18 risk [Likelihood] in Fetus

277

0.85

0.39

1.7

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

581

1.10

0.39

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

775

5176

1.03

0.39

1.1

titre

127.9

214.2

0.86

122

(3038026) Centromere Ab [Units/volume] in Serum

161

1194

0.93

0.39

1.1

1.2

u/ml

80.5

59.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

223

1635

0.94

0.39

1.2

u/ml

60.7

55.5

0.09

121

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.38

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

194

1253

1.07

0.38

1.6

u/ml

25.3

25.6

0.03

280

(3005033) Fetal Nuchal fold Thickness US

276

0.85

0.38

1.7

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

261

0.85

0.38

3.5

2.8

—

(4015189)

451

1.12

0.38

1.6

2.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.38

0.38

1.0

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

1066

7164

1.03

0.37

1.3

u/ml

186.4

225.2

0.53

976

6609

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

856

5735

1.03

0.37

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

283

1.15

0.36

1.4

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

559

3719

1.04

0.36

1.6

iu/ml

15.2

7.1

0.32

139

820

(3047181) Lactate [Moles/volume] in Blood

620

4133

1.04

0.36

5.1

5.7

mmol/l

1.3

0.05

539

3668

(3009677) Dengue virus Ab [Presence] in Serum

1.43

0.36

1.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

316

1.14

0.35

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

316

1.14

0.35

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

187

1.18

0.35

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

403

2666

1.04

0.35

1.4

e6/l

84.7

27.0

0.73

304

2098

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.38

0.35

1.0

u/l

206.3

609.5

—

(3037522) Nuclear Ab [Titer] in Serum

2526

17159

1.02

0.34

1.3

titre

473.5

574.8

2.29

545

3878

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

403

2669

1.04

0.34

1.4

e6/l

6209.3

1525.9

0.41

323

2215

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.33

0.34

2.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

599

0.91

0.34

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.67

0.33

2.0

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

112

1.23

0.33

1.2

1.3

10.3

23.2

—

(3004616) Nuclear Ab [Presence] in Serum

242

1756

0.95

0.32

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

505

3368

1.03

0.31

3.8

3.2

mmol/l

1.5

1.6

1.35

494

3298

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

569

4049

0.97

0.31

1.8

1.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.35

0.31

1.0

—

(4306422)

214

1555

0.95

0.31

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

111

824

0.93

0.30

1.5

1.3

u/l

40.6

37.2

0.47

604

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

171

1.17

0.30

1.2

1.5

mu/l

443.0

839.8

1.00

163

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

123

791

1.07

0.30

1.3

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

401

2870

0.96

0.30

1.2

u/ml

0.6

16.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

122

785

1.07

0.30

1.3

1.2

—

(1002224) Polysomnography panel

572

4066

0.97

0.29

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

254

0.87

0.29

1.2

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

206

1496

0.95

0.29

1.1

119.0

118.4

0.09

184

1336

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.75

0.29

2.8

2.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

239

0.87

0.29

1.0

u/ml

0.9

0.01

114

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

289

1.12

0.29

1.1

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.24

0.29

2.9

2.5

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

172

1.16

0.29

1.2

1.5

73.3

71.7

0.26

164

(4094501)

561

3983

0.97

0.28

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.25

0.27

1.9

1.6

—

(4146454)

259

1865

0.96

0.27

2.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

162

1057

1.06

0.27

1.3

titre

475.7

405.8

0.16

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

363

1.10

0.27

1.2

1.3

nmol/l

124.2

141.2

0.38

251

(3015183) Erythrocyte sedimentation rate

411

0.91

0.27

1.9

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

489

1.09

0.27

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

109

1.20

0.27

1.1

u/ml

0.0

0.8

1.07

(3015171) Extractable nuclear Ab [Units/volume] in Serum

762

5133

1.02

0.26

1.2

u/ml

0.9

0.8

0.22

473

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.27

0.26

1.2

1.3

mg/l

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

104

670

1.07

0.26

1.1

iu/ml

16.1

10.6

0.88

131

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

530

1.08

0.26

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.29

0.25

1.1

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

597

1.07

0.25

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

158

1149

0.95

0.25

1.1

97.2

94.6

0.60

148

1073

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

118

0.82

0.25

1.4

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

102

658

1.07

0.25

1.3

g/l

1.6

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

120

779

1.06

0.24

1.1

nmol/l

0.9

5.7

4.04

159

(3001186) Copper [Moles/volume] in Serum or Plasma

260

1.11

0.24

1.1

1.2

umol/l

17.8

16.5

1.02

239

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

242

1602

1.04

0.24

1.3

1.2

nmol/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

104

1.19

0.24

1.1

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

156

1022

1.05

0.24

1.3

titre

75.4

60.6

0.30

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

303

2017

1.04

0.23

1.5

62.3

59.2

0.67

182

1281

(3010937) Rubella virus Ab [Presence] in Serum

1.33

0.23

1.2

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.20

0.23

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

243

1611

1.04

0.23

1.2

u/ml

3.6

3.9

0.10

556

(4211845)

114

741

1.06

0.23

3.6

3.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

314

1.10

0.23

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

275

1967

0.96

0.23

1.8

pmol/l

200.2

195.5

0.33

246

1835

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

137

1.16

0.23

1.1

—

(3000285) Sodium [Moles/volume] in Blood

226

0.88

0.22

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

262

0.89

0.22

1.9

1.5

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.1

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.22

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

158

1142

0.95

0.22

1.1

au/ml

131.3

52.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

512

0.93

0.21

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.19

0.21

1.0

4.4

—

27.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

123

0.84

0.21

1.1

u/ml

82.9

60.4

0.44

117

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

117

764

1.06

0.21

1.5

1.4

4.4

3.74

164

(3032868) Hemoglobin electrophoresis panel in Blood

1.21

0.21

1.6

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

503

1.07

0.21

2.4

2.2

umol/l

60.2

57.3

0.33

391

(3039443) Prostate specific Ag panel - Serum or Plasma

309

2065

1.03

0.20

1.7

1.6

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.20

0.0

7.6

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

246

0.90

0.20

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

286

1909

1.03

0.20

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

145

1.14

0.20

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

310

1.09

0.20

1.0

1.1

umol/24h

0.6

0.7

0.21

137

(40759836) Histone Ab [Presence] in Serum by Immunoblot

138

907

1.05

0.20

1.1

1.2

—

(44806071)

144

0.86

0.20

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

384

1.08

0.19

1.4

1.2

24.5

23.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

138

910

1.05

0.18

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

138

910

1.05

0.18

1.1

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.18

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

308

0.92

0.18

1.2

1.3

mg/l

1.1

22.2

0.71

234

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

386

1.07

0.18

1.6

1.5

ug/l

0.5

0.4

0.56

240

(3011325) HIV 1+2 Ab [Presence] in Serum

1.15

0.17

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.15

0.17

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.23

0.17

2.0

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

421

0.93

0.17

1.1

miu/ml

1640.6

1638.7

0.00

421

(3022621) pH of Urine by Test strip

1329

9276

0.99

0.16

3.2

3.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

138

914

1.04

0.16

1.1

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.83

0.16

1.0

1.3

—

(4027681)

526

0.94

0.16

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

112

0.86

0.16

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

135

1.12

0.16

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

138

915

1.04

0.16

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

142

1.12

0.15

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

138

916

1.04

0.15

1.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

490

1.06

0.15

1.3

61.4

57.2

0.43

426

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

248

0.92

0.15

2.1

1.7

mmol/l

1.2

0.39

239

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.78

0.14

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

511

1.05

0.14

2.9

umol/l

27.5

28.3

0.31

383

(3029075) Extractable nuclear Ab panel - Serum

350

1.06

0.14

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

303

1.07

0.14

1.4

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

476

3343

0.98

0.14

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

431

0.94

0.14

1.1

100.1

98.0

0.12

329

(3017315) Amylase [Enzymatic activity/volume] in Urine

108

715

1.04

0.14

1.2

u/l

178.2

340.4

2.29

662

(3035933) Granulocytes/100 leukocytes in Blood

183

1.09

0.14

1.2

1.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

642

0.96

0.14

5.9

4.5

u/ml

7859.6

515.1

0.44

103

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

235

1579

1.03

0.13

1.2

u/ml

3.3

4.0

0.54

107

707

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

388

0.94

0.13

1.5

1.6

ug/l

9.3

9.1

0.13

388

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

345

0.94

0.13

1.4

1.2

114.9

113.4

0.16

303

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

110

0.88

0.13

1.8

1.4

39.1

47.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

311

1.06

0.13

1.2

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

556

0.96

0.12

1.3

1.2

63.1

54.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

661

0.96

0.12

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

628

4271

1.01

0.12

1.4

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.17

0.12

1.2

g/l

0.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

632

0.96

0.12

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

127

905

0.97

0.12

2.1

1.6

u/l

604.1

2410.5

1.83

337

(3002523) Influenza virus A Ag [Presence] in Specimen

156

1045

1.03

0.12

1.1

—

(3017569) Oxygen content in Arterial blood

101

671

1.04

0.12

1.9

2.0

—

(3020491) Glucose [Moles/volume] in Blood

144

964

1.03

0.11

2.3

2.0

mmol/l

7.4

7.1

0.73

103

654

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

229

1544

1.02

0.11

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

187

0.92

0.11

3.2

2.9

u/field

0.5

0.6

0.11

187

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

417

2831

1.02

0.11

1.5

1.8

iu/l

6.5

7.6

0.12

968

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

139

1.09

0.10

1.0

1.1

umol/24h

1.4

1.7

1.48

139

(3016330) Potassium [Moles/time] in 24 hour Urine

186

1.08

0.10

1.2

—

88.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

664

0.97

0.10

1.8

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.87

0.09

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

157

0.92

0.09

10.0

10.2

—

(4133840)

298

0.95

0.09

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

155

1044

1.02

0.09

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.09

0.09

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

144

1017

0.98

0.08

1.1

1.2

—

(3022689) Creatine [Moles/volume] in Urine

445

1.04

0.08

1.6

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.82

0.08

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.13

0.08

1.3

umol/24h

359.2

305.6

0.37

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.10

0.08

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

351

1.04

0.08

1.1

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.83

0.08

12.2

8.5

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.81

0.07

1.2

—

17.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

101

1.09

0.07

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.86

0.07

4.9

7.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

128

1.08

0.07

10.9

1.8

mmol/l

7.5

7.2

0.13

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.83

0.07

1.1

mmol/l

7.6

8.6

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.85

0.07

1.3

1.2

—

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

372

0.96

0.06

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

146

989

1.02

0.06

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1014

7029

0.99

0.05

1.2

iu/ml

117.4

134.1

0.73

321

2654

(3000034) Microalbumin [Mass/volume] in Urine

203

1382

1.01

0.05

3.7

3.0

mg/l

49.9

44.4

0.15

143

984

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.11

0.05

5.7

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

105

738

0.98

0.05

1.1

mg/l

67.1

42.3

0.65

623

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

608

1.02

0.05

1.1

ratio

1.1

0.06

209

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

515

0.98

0.04

1.5

1.8

umol/l

78.8

116.0

1.26

273

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

369

0.97

0.04

1.3

1.2

g/l

0.3

0.06

303

(3019174) dRVVT (LA screen)

103

1.07

0.04

1.1

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

103

1.07

0.04

1.1

—

(4268621)

156

1062

1.01

0.04

2.3

—

(40762814) Titanium [Mass/volume] in Blood

349

1.03

0.04

2.1

2.3

ug/l

2.8

3.6

1.74

124

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

405

1.02

0.03

1.2

1.3

29.4

36.8

0.77

267

(3044242) Glucose [Moles/volume] in Arterial blood

665

0.99

0.03

1.6

1.8

—

(44813793)

121

845

0.99

0.03

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

127

886

0.99

0.03

1.1

1.0

mg/l

304.3

287.9

1.70

106

795

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.07

0.03

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

103

701

1.01

0.03

1.0

1.1

mg/l

402.1

289.4

0.77

626

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

550

3777

1.00

0.03

2.6

2.3

ug/min

127.6

107.3

0.42

311

2157

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

454

1.02

0.02

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

276

0.97

0.02

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

217

1487

1.01

0.02

1.3

1.2

—

(3019977) pH of Arterial blood

112

780

0.99

0.02

1.9

2.4

7.4

1.25

268

(3014599) Egg white IgE Ab [Units/volume] in Serum

413

0.99

0.01

1.0

u/ml

0.6

0.5

—

100

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

284

1.02

0.01

3.4

2.9

mg/l

8.5

6.8

0.96

229

(3034426) Prothrombin time (PT)

353

1.02

0.01

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

194

1345

0.99

0.01

1.3

—

43.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

505

1.01

0.01

1.0

1.1

ng/l

751.6

764.0

0.01

122

(3038177) Helicobacter pylori Ab [Presence] in Serum

261

1794

1.00

0.01

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

216

1484

1.00

0.01

1.4

1.5

21.7

28.5

2.31

123

926

(3010144) Erythrocytes [#/volume] in Synovial fluid

221

1520

1.00

0.00

1.3

e6/l

91130.2

140268.3

0.62

150

1043

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

195

1349

1.00

0.00

1.1

iu/ml

4.0

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

122

1.02

0.00

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

111

0.99

0.00

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

319

0.99

0.00

2.0

2.6

mmol/l

6.8

7.8

1.48

196

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

108

741

1.01

0.00

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

212

1.01

0.00

1.5

1.3

54.8

47.1

0.35

(3037556) Urate [Mass/volume] in Serum or Plasma

490

1.00

0.00

1.6

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.99

0.00

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

125

0.99

0.00

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

121

1.03

0.00

1.1

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

338

1.00

0.00

1.7

1.5

ng/l

150.9

114.5

0.72

338

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

101

1.02

0.00

2.0

2.2

mmol/l

1.6

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

518

1.00

0.00

1.0

1.1

u/l

1.2

1.1

0.86

252

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

142

1.02

0.00

1.5

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

155

0.98

0.00

1.8

1.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

328

1.01

0.00

1.0

u/ml

0.1

0.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

172

1185

1.00

0.00

1.1

—

23.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.00

0.00

1.0

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

22.9

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.89

0.00

1.6

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.86

0.00

1.4

1.2

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BASAL_CELL_CARCINOMA_EXALLC – Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

GWS hits: 102

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Basal cell carcinoma, excluding all cancers (controls excluding all cancers) (C3_BASAL_CELL_CARCINOMA_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints